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Abstract
Retinal degeneration can be caused by many genetic mutations. The Pde6b- 
mutation affects rod photoreceptors, which are lost in mice by post-natal day ( P \ D )  21 
(Marc et ah, 2003: Chang et ah, 2002). Mice that are homozygous for the Pde6b- 
mutation are born with vision and go blind over time. Behavioral studies suggest that 
Pde6b- mice lose their visual acuity by age PND 42 and subsequently lose their ability to 
detect differences in light illumination by PND 100. Behavioral changes have been 
correlated with changes in gene expression in specific cells in earlier studies. In this 
study, gene expression changes were examined for astrocytes in the visual cortex using 
real-time PCR for astrocyte-specific genes GFAP, Vimentin and S I 00. GFAP and 
vimentin have been found to be useful for identifying the link between behavioral 
changes and their corresponding gene expression pattern changes (Kafitz et ah. 1999). 
S I 00 mRN A  expression is also useful because it can influence GFAP and vimentin at the 
protein level (Muller et ah, 1993). It was hypothesized that astrocyte-specific gene 
expression changes will be found at relevant ages (PND 21, 42 and 100) in astrocytes of  
the visual cortex in our Pdebb- mice compared to Pde6b+ mice, due to remodeling after a 
loss o f  visual function indicated by behavioral changes at these ages. We hypothesize 
that GFAP expression will decrease, v imentin expression will increase and we are not
sure what  will happen to the expression of  S100 at these relevant ages. Results suggest 
that changes in gene expression are taking place at PND 7. 21 and 49. Our hypothesis 
may not be fully supported at the ages where behaviors were changing, but our data do 
suggest changes in gene expression at other possibly relevant ages. PND 21 was the age 
that showed a change in gene expression for vimentin coinciding with the age that rod 
photoreceptors are lost. This age could be examined further at the protein level for the 
glial genes.
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Chapter  One: History & Introduction
Links between behavior and specific brain areas/cell types: brain rem odeling and 
plasticity
Behavioral changes are tied to changes in specific brain areas as well as specific 
cell types. The ability o f  the brain to change is called brain plasticity. This is not a new 
idea; many studies have demonstrated this in the past (Kafitz et ah. 1999). One example 
is seen in canaries. Every spring, mature male canaries learn an elaborate song in order 
to find a mate. The brain region responsible for male canaries learning a song is the 
higher vocal center (HVc),  that when damaged will result in the loss o f  the song behavior 
(Kafitz et ah, 1999). Interestingly, songbirds can sing only during the springtime. This is 
when significant morphological changes are occurring in HVc neurons (Kafitz et ah, 
1999). The morphological changes found in HVc neurons are mirrored in HVc astroc\ les  
at the same time (Kafitz et ah. 1999). Astrocytes can guide neurons by regulating neurite 
extension and outgrowth and neural synapse formation during remodeling (i.e. plasticity) 
(Kafitz et ah, 1999; Rochefort et ah, 2002; Privat, 2003; Argandona et ah, 2003). Kafitz 
et ah (1999) demonstrated seasonal changes in patterns o f  gene expression in astrocytes 
in the HVc of  male canary brains.
Vimentin and filial Fibrillary Acidic Protein (GFAP) were used as astrocyte- 
specific cell markers (Kafitz et ah, 1999). Vimentin and GFAP are type 111 intermediate 
filament proteins (Matsuzawa et ah, 1997) that can be visualized via labeling with their 
respective antisera. Immature astrocytes are labeled with vimentin antisera and mature 
astrocytes are labeled using GFAP antisera (Kafitz et ah, 1999). Kafitz et ah found that
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vimentin expression increased while the songs were becoming stable and concluded that 
vimentin promotes brain plasticity. They also found that CiFAP expression increases 
when the song was stable and concluded that CiFAP inhibits brain plasticity. These 
results suggest that behavioral changes may be triggered by gene expression changes in 
specific cell types. This model o f  brain plasticity can be applied to other situations w here 
behavioral changes are linked to modificat ions in gene expression. Our study focused on 
changes in gene expression corresponding to behavioral changes due to retinal 
degeneration.  The behavioral studies, discussed later, identify potentially important time 
points to examine gene expression pattern changes in the visual cortex. It is hypothesized 
that we will find gene expression pattern changes in specific cell types at relevant time 
points during development.
Vision loss (Pde6b- mice) and behavior change
Vision loss can be caused by many different genetic mutations. Retinal 
degeneration (RD) can cause photoreceptor  death, which ultimately results in vision loss 
(Chang et ah, 2002). Mouse models have been used to inv estigate retinal degeneration to 
elucidate the mechanism o f  photoreceptor  death (Chang et ah, 2002). Chang et ah 
summarized 16 different mouse models o f  retinal degeneration affecting mice at varying 
ages and genome locations. Two o f  these RD mice hav e mutations in the gene encoding 
the beta subunit o f  phosphodiesterase type 6 (Pde6b), located on mouse chromosome 5 
(Pde6brdl and Pde6brdl°) (Chang et ah. 2002). Phosphodiesterase Type 6 (Pde6) contains 
three subunits: alpha, beta and gamma (Figure 1). Wild type Pde6b codes for the beta
subunit.  The main function o f  Pde6 beta and alpha is to hydrolyze cG M P  when active 
and be inhibited by Pde6 gamma when inactive (lonita et ah. 2007).
Figure 1: Phosphodiesterase ty pe 6
F i g u r e  1: P r o p o s e d  s t r u c t u r e  o f  p h o s p h o d i e s t e r a s e  t y p e  6.  s h o w i n g  its t h r e e  s u b u n i t s  a n d  t he  d o m a i n s  o f  t he  
a l p h a  ( a )  a n d  b e t a  ((3) s u b u n i t s .  G A F - I  a n d  G A F - 2  a r e  n o n - c a t a l y t i c  c G M P  b i n d i n g  d o m a i n s ,  a n d  C A T  is 
t h e  c a t a l y t i c  d o m a i n .  P d b 6  g a m m a  (y)  is in t h i s  m o d e l  t o i l l us t r a t e  t h e  t w o  b i n d i n g  d o m a i n s  o n  e a c h  o f  t h e  
a  a n d  (3 s u b u n i t s .  ( T h i s  f i g u re  is d e r i v e d  f r o m  t h e  m o d e l  in l o n i t a  e t  a!. .  2 0 0 7 ) .
Pde6 is found in rod photoreceptors and is o f  significant importance in the 
phototransduction cascade (lonita et ah, 2007). This enzyme regulates the levels o f  rod 
excitation in the presence and absence o f  light stimulation (lonita et ah, 2007). During 
light stimulation rhodopsin is activated, which in turn activates transducin, a G-protein, 
by causing it to exchange GDP for GTP. GTP-transducin activates Pde6 by displacing its 
gamma subunits (Blumer,  2004; lonita et ah, 2007). When activated, the Pde6 alpha and 
beta catalytic sites hydrolyze cG M P to GMP, decreasing the intracellular level o f  cGMP. 
Decreased levels o f  cGM P close the cGMP-gated Na+ ion channels and cause 
hyperpolarizat ion o f  the rod plasma membrane  (Blumer, 2004; lonita et ah, 2007). This 
activates rod photoreceptors and causes a signal to be sent to the brain. In the absence of  
light other enzymes in the phototransduction pathway turn off  the light-induced response
by increasing the rate at which transducin hydrolyzes bound ( H P  (Blumer.  2004: 
lonita et al.. 2007). This yields the inactive GDP-transducin leading to cGMP-gated ion 
channels  opening and polarization returning to normal (Blumer, 2004: lonita et al.. 2007 ).
Pde6brtJI mice have a murine viral insert plus a nonsense mutation in the 7lh exon 
o f  the Pde6b gene (Chang et al., 2002). This causes production o f  a truncated and non­
functional form o f  Pde6b protein (Jones and Marc, 2005). The non-functional Pde6b 
protein ultimately leads to rod photoreceptor  degeneration,  which is followed by cone 
degenerat ion due to a mechanism illustrated by Marc et al. (2003). Mice homozygous for 
this mutation experience severe retinal degeneration (Chang et al., 2002).
Pde6br<" strain FVB/N-Tg(GFAPGFP)14Mes/J  (stock #003257) from Jackson 
Laboratories ( J A X U Mice and Services; Bar Harbor, MA) was chosen for the retinal 
degeneration strain o f  mice. Henceforth,  this strain will be called Pde6b- or retinal 
degeneration (RD) mice. These transgenic mice are useful because the)’ have the gene 
encoding a mutant form o f  green fluorescent protein (GFP: mutant HGFP-S65T) inserted 
into their genome under the control o f  the astrocyte-specific promoter  for GFAP (JAX" 
Mice and Services: Bar Harbor, MA). The GFP gene, derived from a jelly fish, Aequorea  
victoria, will emit fluorescence when subjected to a 488nm light source and illuminate 
the astrocytes expressing ample GFP (used as an indirect measure o f  GFAP expression) 
( J A X “ Mice and Services: Bar Harbor, MA).
Pde6brJI strain FVB.l29P2-Pde6b+ T yf"dl/AntJ (stock #004828) from Jackson 
Laboratories (JAX'* Mice and Services: Bar Harbor, MA) was chosen for the wild type, 
control strain. These mice will be called Pde6b+ or wild type (WT). These mice do not
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suffer from retinal degeneration because the} are homozygous for the wild type Pdebh 
allele (JAX * Mice and S e n  ices: Bar I larbor. MA).
The Pde6b- mice have phenolypically normal vision at birth and with time lose 
their vision completely.  First, Pde6b- mice lose night vision via death o f  rod 
photoreceptors.  Next,  their cones begin to degrade leading to a loss o f  visual acuity. 
Visual acuity can be defined as the sharpness or focus in vision. Cone function degrades 
until there are too few cones present to function properly, leading to a loss o f  the ability 
to detect differences in light illumination (having this ability is similar to being able to 
see that individual ceiling tiles are lit up rather than the entire ceiling being illuminated). 
Elegant behavior tests were done to establish the time point o f  each stage o f  vision 
degradation.  Dr. Jarvinen and undergraduate students in the Psychology Department o f  
the University o f  Michigan-Flint did these tests, summarized below.
To determine when visual acuity was lost, the Pde6b- mice were lowered down 
over sand paper o f  different grades (smooth, medium and coarse). The mice were held 
by the tail and quickly lowered down to the surface o f  each grade o f  sand paper where 
they would splay their legs (or not) before impact. If  the mice had normal vision, they 
would splay their legs before impact on ail sand paper grades. Retinal degeneration 
became apparent when the mice would lose their ability to react to the smooth,  and later 
medium, sand paper and would not splay their legs. When the mice would no longer 
splay their legs for the coarse sand paper, visual acuity was lost. Behav ior changed and 
visual acuity was lost in RD mice by post-natal day (PND) 42.
To determine when the ability to discriminate between differences in light 
illumination was lost, the Pde6b- mice w ere subjected to a series o f  experimental settings
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called phases. The phases were set up in a box with gridlines in a controlled room where 
no distractions would influence the mouse 's  behaxior. Tine mice were measured for lime 
spent in each square o f  the grid. Phase 1 was set up so that the light shining down into 
the box was most  intense in one particular corner (Figure 2). Here the mice spent equal 
amounts o f  time in each square on the grid (Graph 1). Phase 2 w as set up in the absence 
o f  light w ith an interesting smell (pheromone) placed in a corner (i.e., where the light was 
most intense from Phase 1) (Figure 3). The bedding was changed with each new phase as 
a control measure. Here the mouse spent significantly more time in the “ scent square." or 
“Hot" partition (Graph 1). The mouse associated the interesting smell with the partition 
from the amount o f  light that w'as previously in that partition from phase 1. Phase 3 was 
set up the same as phase 1 (Figure 4): mice spent significantly more time in the square 
where the scent used to be, the “Hot" partition until they were incapable o f  detecting 
differences in light illumination (Graph 1). It was found that Pdebb- mice are capable of  
detecting differences in light illumination until PND -100 ,  or between PND 91 and 1 12 
(Graph 1).
Data from other laboratories suggest that Pde6b- mice lose rods by PND 21 (Marc 
et al., 2003: Chang et ah, 2002). Rods are located in the outer nuclear layer (ONL) o f  the 
retina (Marc et al., 2003) and the ONL is lost in mice homozygous for the Pde6b- allele 
by PND 21 (Chang et al., 2002): therefore, rods were lost by PND 21. The behavioral 
tests described above suggest that these mice lose visual acuity by PND 42 and lose the 
ability to detect differences in light illumination by PND 100. These behavior 
experiments set the stage for molecular studies by giving specific time points to monitor  
for potential changes in gene expression. The important time points PND 21 (loss of
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night vision). 42 (loss o f  visual acuity) and 100 (loss of  the abilitv to detect differences in 
light illumination) are when we expect to find changes in gene expression.
Figure 2: Phase 1 of light illumination behavior test
F i g u r e  2: P h a s e  1 o f  b e h a v i o r a l  t es t  t o  s e e  i f  t h e  m i c e  c a n  d i s c r i m  ina l e  b e t w e e n  d i f f e r e n c e s  in l ight  
i l l u m i n a t i o n .  T h i s  p h a s e  h a d  l ight  o n l y :  t h e  P d e 6 b -  m i c e  s p e n t  e q u a l  a m o u n t s  o f  t i m e  in e a c h  s q u a r e .  
S q u a r e  w i t h  m o s t  i n t e n s e  l ight  is i n d i c a t e d  b y  a n a s t e r i s k  (*) .
Figure 3: Phase 2 of light illumination behavior test
o
F i g u r e  3: P h a s e  2 o f  b e h a v i o r a l  tes t  t o se e  i f  t he  m i c e  c o u l d  d i s c r i m i n a t e  b e t w e e n  d i f f e r e n c e s  in l ight  
i l l u m i n a t i o n .  T h i s  p h a s e  h a s  an  i n t e r e s t i n g  s c e n t  o n l y ;  t h e  m i c e  s p e n t  s i g n i f i c a n t l y  m o r e  t i m e  in s m e l l  
s q u a r e ,  w h i c h  h a d  t h e  m o s t  l ight .  T h e  s q u a r e  w i t h  t he  i n te r e s t i n g  s m e l l  w a s  c o n s i d e r e d  t h e  “ Plot "  p a r t i t i o n  
i n d i c a t e d  h e r e  w i t h  a c i r c le  ( O ) .  T h e  P d e 6 b -  m i c e  l ea r n e d  to a s s o c i a t e  t h e  i n t e n s e  l ight  w i t h  t h e  i n t e r e s t i n g  
s me l l .
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Figure 4: Phase 3 o f  light illumination behavior test
F i g u r e  4: P h a s e  3 o f  b e h a v i o r a l  t es t  to se e  i f  t he  P d e 6 b -  m i c e  c a n  d i s c r i m i n a t e  be tw e e n  d i f f e r e n c e s  in l ight  
i l l u m i n a t i o n .  T h i s  p h a s e  w a s  set  up  w i t h  l ight  o n l y :  t h e  m o u s e  s p e n t  s i g n i f i c a n t l y  m o r e  t i m e  in t he  s q u a r e  
w h e r e  t he  s c e n t  w a s  ( i n d i c a t e d  by O )  unt i l  t he  a b i I i t \  t o d e t e c t  d i f f e r e n c e s  in l ight  i l l u m i n a t i o n  w a s  lost  ( t he  
w e l l  lit s q u a r e  i n d i c a t e d  b y  *).
Graph 1: Sum mary o f  data from each phase o f  the light illumination behavior test
f   p fTaS'
CSZ3 Ftm-’
c
9 160
q  140
n
14-21 4 9 91
Postnatal Age (inda )^
G r a p h  1: S u m m a r y  o f  d a t a  f r o m  b e hav  ioral  t es t  d e t e r m i n i n g  at w h a t  a g e  P d e b b -  m i c e  lost  t h e i r  abi l i ty to 
d e t e c t  d i f f e r e n c e s  in l ight  i l l u m i n a t i o n  ( P h a s e  I: l ight  o n l y :  P h a s e  2: s c e n t  o n l y :  P h a s e  3: l ight  w h e r e  s c e n t  
w a s ) .  T h e  s q u a r e  w i t h  t he  i n t e r e s t i n g  s m e l l  w a s  c o n s i d e r e d  t he  " H o t "  s p o t  o r  p a r t i t ion .  ^ ^ S i g n i f i c a n t  
d i f f e r e n c e  in t i m e  s p e n t  in " H o t "  P a r t i t i on  o f  p h a s e  3 w a s  s e e n  b e t w e e n  P N D  91-1 12.
For the molecular studies, we studied changes in gene expression in the \ isual 
cortex. The rational behind choosing the visual cortex was two fold. First, the eye sends 
information directly to the thalamus and then to the v isual cortex (Figure 5). One could 
argue that the better place to sample would have been the thalamus. However, the 
thalamus was not sampled because that region o f  the brain is difficult to excise in its 
entirety. In contrast, Dr. Jarvinen was confident that each time he removed the visual 
cortex, he had isolated all o f  it and the sample contained no other tissue.
Figure 5: Sensory perception pathways
Eve
F i g u r e  5:  D u r i n g  s e n s o r y  e n d o c r i n e ,  i n f o r m a t i o n  is p a s s e d  t h r o u g h  t he  t h a l a m u s  b e f o r e  f u r t h e r  p r o c e s s i n g  
in t h e  s e n s o r y  c o r t i c e s .
Astrocytes and their involvement in plasticity: GFAP, vimentin and S100
As previously shown by Kafitz et al. (1999), astrocyte cells are critically 
important for neural plasticity. Astrocytes are a class o f  glial cells that hav e been found 
to play an active roll in synaptogenesis o f  neural cells in the brain (Ullian et ah. 2004). 
Astrocvles compose almost 50% of  the cells in the brain (Ullian et ah, 2004) and are 
found to compose about 28% o f  the cells in the v isual cortex (Gabbott and Stewart.,
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1987). They can be recognized by their morphology: these cells ha \e  man} processes 
(Argandona et al., 2003). which reach out and form complex networks with surrounding 
neurons and interneuron synapses (Piet et ah. 2003). In the past, astrocytes were thought 
to be passive cells that nourished neurons and provided them with a favorable 
environment (Rochefort et ah, 2002, Ullian et ah, 2004). Astrocytes do prov ide neurons 
with an energy supply and an ion balance, but they are also involved in plasticity where 
they guide neural axons and regulate neural activity (Rochefort et ah, 2002; Privat, 2003: 
Argandona et ah. 2003).
When stimulated, neurons release neurotransmitters from their axons into the 
synapse in order to communicate with other neurons (Piet et ah, 2003). It has been found 
that these neurotransmitters are not always kept confined to the synapse where they were 
released, but can travel into the extracellular space and stimulate neighboring neurons 
(Piet, et ah, 2003). This is called intersynaptic crosstalk (Piet et ah. 2003). Astrocytes 
hav e been found to be key regulators o f  intersynaptic crosstalk in vitro: independent 
synapses show increased crosstalk when astrocyte processes were withdrawn suggesting 
the ability o f  astrocytes to regulate the activities of  neurons (Piet et ah. 2003).
It has also been found that the majority o f  the brain's synaptic structure is formed 
by PND 21 in mice (Ullian et ah, 2004). The astrocyte-specific cell marker found in 
immature astrocytes is an intermediate filament (IF) protein called vimentin (Dahl et ah. 
1981: Privat, 2003: Kafitz et ah, 1999: Messing and Brenner. 2003). After PND 21. 
mature astrocytes can be identified with another IF protein called GFAP (Privat. 2003: 
Kafitz et ah, 1999: Messing and Brenner, 2003) along with S I 00, a calcium binding
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protein (Argandona et al.. 2003: Mailer  et al.. 1003). (JFAP. \ imenl in and S 100 are 
believed to be important for regulating the interactions between astrocytes and neurons.
GFAP and vimentin are IF type III proteins that help maintain astrocyte cell 
structure and integrity (Argandona et al., 2003: Goldman et al.. 1996). GFAP was first 
isolated in brain plaques o f  multiple sclerosis patients over 35 years ago by Larry Eng 
(Eng et al.. 2000). The function of  GFAP in astrocytes w as elucidated in a murine model 
using both null (no protein) and modified (elevate protein) alleles o f  the GFAP gene 
(Messing and Brenner. 2003). They found only subtle effects without GFAP expression 
during development (GFAP null mice). This could be explained by the presence o f  
vimentin earlier in development. Interestingly, they found significant phenotypic effects 
in mice having elevated expression o f  GFAP (GFAP elevated mice), with similar 
symptoms to Alexander 's  disease, a serious neurodegenerative disorder. Symptoms 
include developmental  delays and changes in physical characteristics. One explanation 
o f  this disorder caused by the elevated expression o f  GFAP could be due to a toxic 
intermediate in the assembly o f  this IF protein (Messing and Brenner, 2003).
Another study also found that excess GFAP is detrimental to the nervous system's 
ability to be plastic. Privat (2003) found that expression o f  GFAP in mice that experience 
CNS injuries results in a lower rate o f  neuronal surviv al and neurite extension. This is 
most likely due to mature GFAP-expressing astrocytes stabilizing previously made neural 
connections and impeding the process o f  establishing new ones. Privat also found that 
mice expressing vimentin alone had a better ability to form new neural connections post- 
CNS injury. This again suggests that immature, vimentin-expressing astrocytes promote 
neural plasticity.
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As discussed earlier, Kafitz et al. (1999) also found that immature,  vimenlin- 
expressing astrocytes promote plasticity while mature, GFAP-expressing  astrocytes 
inhibit plasticity. The expression o f  these two glial genes is o f  interest to our study in 
relation to Pde6b- mice development. Theoretically, these mice need to have the ability 
to make changes in their brains due to the loss o f  a very crucial sense (vision). Once 
remodeling takes place (i.e. auditory senses enhanced), these changes must  then become 
stable (i.e. inhibition o f  plasticity). For remodeling to occur, we would expect to see an 
increase in the expression o f  vimentin. For subsequent stability to secure these newly 
remodeled neural pathways, we w'ould expect to see an increase in GFAP expression.
The last protein o f  interest in this study is S I 00, a calcium binding protein that 
was first isolated from a cow 's  brain in 1965 by Moore (Muller et al., 1993). The S I 00 
protein family has 21 members (Donato, 2003), o f  which the S100B form is most 
com mon in astrocytes in the brains o f  mammals  (Rothermundt et al., 2003). S I 00 
proteins exist functionally as homodimers that become activated by calcium (Donato, 
2003).  This promotes a conformational change that al lows S100B to bind to target 
proteins such as GFAP and vimentin (Donato, R., 2003). The functional consequence o f  
this interaction is not completely understood.
S I 00 proteins have been seen to have regulatory activities both intracellularlv and 
extracellularly. Intracellularlv, S100B regulates protein phosphorylat ion,  the dynamics of  
cytoskeleton constituents, calcium homeostasis, etc. (Danato, 2003). In particular, S100B 
inhibits the phosphorylat ion of  GFAP and vimentin (Rothermundt et al., 2003). It is 
suggested that binding o f  calcium-activated S100B to GFAP and vimentin prevents the 
assembly o f  the intermediate filament proteins by holding individual subunits and
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sequestering them (Donato,  2003: Rothermundt et al., 2003). S I 00 proteins are main)} 
located in the astrocyte cell body rather than the processes (Argandona et al.. 2003). It 
has been found that S I 00 proteins are expressed at the same t ime points as GFAP in 
mature astrocytes, with the greatest concentration seen during senescence (Muller et al., 
1993). Extracellularly, S I 00 has been found to regulate the activities o f  neurons and 
other  astrocytes (Donato,  2003). The extracellular concentration o f  S I 00 is crucial for 
physiological effects. In nanomolar  concentrations, S I 00 has been found to regulate 
astrocytes and neural activity normally; S100B stimulates neurite outgrowth and 
enhances the survival o f  neurons and astrocytes (Rothermundt et al.. 2003). In 
micromolar  concentrations,  S I 00 becomes toxic to the surrounding tissue. S100B 
stimulates the expression o f  |3-amyloid protein which in turn stimulates the expression o f  
S100B: this induces apoptosis in several types o f  neural cells (Rothermundt et al., 2003).
Clearly, GFAP, vimentin and S I 00 are o f  enormous interest when studying the 
plasticity o f  the visual cortex in mammals.  The present study examined the expression o f  
genes encoding these proteins in the visual cortex o f  our murine model at specific time 
points throughout development. It was hypothesized that astrocyte-specific gene 
expression changes at PND  21, 42 and 100 in astrocytes o f  the visual cortex in our 
Pde6b- mice compared to Pde6b+ mice. We hypothesize that GFAP expression will 
decrease, vimentin expression will increase and we are not sure what will happen to the 
expression o f  S I 00 at these ages. We initially chose to examine the gene expression 
changes in our murine model first by using end-point PCR. This subsequently led us to a 
more effective method o f  relative quantification o f  gene expression, real-time PCR.
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Gene expression analysis: end-point and real-time PCR
Hnd-point PCR is a well-known lool to amplif\ a gene (genomic DNA) or a copy 
o f  an expressed gene (cDNA made from mRNA) (Valasek and Repa. 2005). This was 
the first technique employed in our project to determine relative gene expression of  our 
genes o f  interest (GFAP, vimentin and S I 00). GAPDH, a reference gene encoding 
glyceraldehyde 3-phosphate dehydrogenase,  was also examined.  GAPDH is expressed 
ubiquitously and constitutively in cells, and its expression should not change in a 
particular cell even when under experimental treatments (Sambrook and Russell. 2001). 
End-point PCR techniques were time consuming,  arbitrary and possibly bias and could 
not detect the very low7 levels o f  expression that we wanted to examine.  Real-time PCR 
was used as a more reproducible, quantitative alternative. I was able to select a kit 
suitable for the project: QuantiFast™ S Y B R a  Green PCR Kit (QIAGEN: Valencia, CA) 
and learn how to use the Mastercycler  ep Reulplcx  from the manual (Eppendorf: 
Westbury,  NY).  Real-time PCR can detect as few as 5 copies o f  an mRN A  transcript 
(Valasek and Repa, 2005), and the time between setting up a reaction and analysis was 
typically one fifth that o f  end point PCR and results proved to be much more reliable. 
The relative quantification method was used for our real-time PCR study (discussed in 
detail later).
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Chapter  Two: Materials and Methods
Brain tissue samples: Pde6b- and Pde6b + mice
Dr. Jarvinen euthanized,  decapitated, and removed mouse brains into an ice-cold 
buffer solution. In total, 64 mice were used in this study (32 Pde6b- and 32 Pde6b^).  
with 10 ages sampled (PND 7, 14, 21, 28, 35, 42, 49, 100, 140 and 250). Each unique 
genotype/age had a sample size o f  three mice with the exception of  PND 100 that had a 
sample size o f  5 mice for each genotype. Dr. Jarvinen excised the visual cortex, keeping 
the mass o f  each tissue sample equal between animals.
RNA Extraction
RNA was extracted from each brain tissue sample using the PureLink™ Micro-to- 
Midi Total RN A  Purification System as instructed by the manufacture (In\i trogen: 
Carlsbad, CA). The RNA sample was stored at -70°C, or used in DNase treatment. 
DNase I, Amplificat ion Grade, was purchased from Invitrogen and used as instructed by 
manufacturer.  DNased RNA samples were also stored at -70°C until used in cDNA 
synthesis.
cDNA synthesis
cDNA synthesis was carried out as instructed by the manufacture using 
Superscript™ III First-Strand Synthesis System for RT-PCR (Invitrogen). cDNA 
synthesis procedures were repeated for every DNase treated RNA sample plus a reverse 
transcription control. The reverse transcription control was exactly the same as the
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cDNA synthesis but added additional water to make up for the absence o f  reverse 
transcriptase, which was called Pseudo-cDNA. This was a control that tested for 
contamination o f  the reagents in cDNA synthesis.
End point PCR using G A PD H  and gel electrophoresis
Both real cDNA and pseudo-cDNA w'ere used to make G APDH PC R  products. 
This  tested the pseudo-cDNA for contamination while confirming the real cDNA was 
intact. These PCR products were subjected to 1% agarose gel electrophoresis in 0.5x 
TBE Buffer for 1 hour at 90 volts. The gel was stained with Ethidium bromide (EB) and 
de-stained in tap water. If  the cDNA reagents were contaminated we would see PCR 
product in the pseudo-cDNA samples. Each o f  our sample cDNAs w;ere tested for a 
single product  o f  561 bps and to verify there was no contamination. Amplificat ion o f  
pseudo-cDNA did not produce any bands.
Quantitative real-time PCR
Real-time PCR primers
Each primer set was designed using Laser Gene Software (DNASTAR; Madison,  
WI). Sequences o f  mouse GAPDH, GFAP, Vimentin and SI 00 genes were obtained from 
GenBank (w w w . n c b i. n 1 m . n i h . gov/Gen ban k; accession numbers X R 0 3 1086.1 
[GAPDH],  N M _ 0 10277.2 [GFAP], N M 0 0 8 6 9 E 2  [Vimentin], NT 039510.2 [ S I 00]). 
The range o f  product size for real-time PCR is between 100-200 bps and the primers 
were designed accordingly (Table 1).
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(Toning of real-time PCR products into p ( 4-TOPO
Each primer set was used to make a PCR product that was used in cloning. PC R 
products were ligated into pCR-4 TOPO cloning \ec to r  by Nickole Hatley and Ghada 
Sharif  using the TOPO TA Cloning® Kit for Sequencing (Invitrogen), as directed by 
manufac turer 's  instructions.
Table 1: Details of PCR products and successful primers used for each gene in our study
Gene Sequence o f  real-time Primers  
(Up and Down)
Size o f  PCR Product  
(base pairs)
G F A P 5 ‘- T T G C A G A C C T C A C A G A C G C T G C G T - 3 ‘ ( 7 8 1 - 8 0 2 )  
y - G C A T G G C G C T C T T C C T G T T - 3 ‘ ( 9 4 0 - 9 5 8 )
172
S100 5 - T A A G A A T C A A G G C A G A C T A C C A A - 3 '  ( 7 3 1 - 7 5 3 )  
5 ' - G T C T G T C T A C T T T C T G G A G C A T - 3 ’ ( 8 8 2 - 9 0 3 )
173
Y'inientin 5 ' - G C C A A A T C C C C T A T G C C C A A A T C A - 3 ’ ( 1 8 3 8 - 1 8 6 1 )  
5 . C C T T C T T T T T A T C T G C A A C A T C T T - 3 '  ( 2 0 0 7 - 2 0 3 0 )
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G A P D H 5 ' - G G C A A G G T C A T C C C A G A G C - 3 '  ( 7 0 4 - 7 2 2 )
5 - C C T T C A G T G G G C C C T C A G A T G C - 3 '  ( 8 4 5 - 8 6 6 )
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T a b l e  1: S e q u e n c e s  o f  u p s t r e a m  a n d  d o w  n s t r e a m  p r i m e r s  f o r  r e a l - t i m e  P C R ,  a n d  t h e  r e s p e c t i v e  s i ze  o f  e a c h
P C R  p r o d u c t  f r o m  e a c h  p r i m e r  set .  T h e  n u c l e o t i d e  p o s i t i o n s  o f  e a c h  p r i m e r  a r e  i n d i c a t e d  in p a r e n t h e s i s .
Transformation into X L l-B lu e
One 100 pi aliquot of  XL I-Blue competent  cells was used for each 
transformation. Each ligation reaction was transformed into X Ll-B lue  cells and plated 
onto LB-ampici llin plates (200 pg/ml ampicillin) using standard protocols as directed by 
“Molecular Cloning: A Laboratory Manual."  (Sambrook and Russell. 2001).
O vernight cultures o f  transformed bacteria
One 15 ml Falcon tube was labeled per  colony, and 5 mis LB broth and 10pl 
Ampicill in (100 mg/ml)  was added to each tube. Next, one colony was transferred to each
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Falcon lube using a sterile pipette lip. The Falcon lube was then \ o r l e \ e d  lor 15 seconds 
and placed on a slanted rack overnight at 37CC.
Plasmid preps, analysis and sequencing
Small scale plasmid purification was done for each sample using Q I A p r e p f  Spin 
Miniprep Kit (QIAGEN; Valencia, CA) as directed by manufacturer 's  instructions. 
Restriction digests o f  plasmids were performed using Eco R1 restriction enzyme to verify 
the presence o f  the PCR product prior to sending plasmid for sequencing. Samples w ere 
sent to the DNA Sequencing Core at the University o f  Michigan, Ann Arbor.
Real-t ime PCR using QuantiFast  SYBR Green
Background and color (SYBR Green) calibration
These steps were done following the manufacturer 's instructions, using the plates 
provided for calibration (Eppendorf).
Real-time PCR optimization of  GAPDH and astrocyte-specific genes 
cDNA amount and final concentration optimization
Suggestions were made for setting up real-time PCR reactions in Table 1 o f  
QuantiFast SYBR Green PCR Handbook 01/2007 (QIAGEN). Using the parameters set 
in this table, a design was made for the initial reactions. These reactions and all 
subsequent real-time PCR reactions, were set up in 96-well plates that were labeled and 
stored in an ice box in the freezer. Keeping each reaction chilled on ice should prevent 
primer dimer formation and also keep the reagents non reactive. These reactions were
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then set up in a Labconco PCR hood to p re \en t any contamination from entering our 
reactions. SYBR Green Master Mix was always half the total reaction am ount and all 
other components were variable. cDNA amount did not exceed 10% (or 2.5pl) o f  the 
final reaction. Using this table, different pi volumes o f  each cDNA concentration 
([cDNA]) were used to begin RT-PCR reactions including: 1 pi [1:10], 2.5 pi [1:10] and 
1 pi [1:4]. Next, 1 pi o f  the upstream and downstream primers were added to each 
reaction to a final concentration o f  1 pM. Finally, RNase Free water was added to 
complete the reaction and to adjust the volume to 25 pi. PCR programs were created for 
each set o f  reactions as directed by the Mastercycler ep Realplcx4 software manual 
(Eppendorf). Each gene was tested using the same sample cDNA. The reaction variation 
(Table 2) that gave the “best results’' was used in subsequent optimization.
Table 2: Reaction component variations used during optimization of real-time PCR primers
Reaction
Components
Variation 1 Variation 2 Variation 3
jliI o f  [cDNAl 1 pi [1:10] 2.5pl  [1:10] l p l  [1:4]
SY B R  Green 12.5 pil 12.5pl 12.5 pi
Up Stream Primer 1 jliI [25 pM] l p l  [25pM] l p l  [25p M ]
Down Stream  
Primer
l p l  [25pM ] l p l  [25pM] l p l  [25pM]
RNase-Free W ater 9.5pl 8 pi 9.5pl
Total 25 pi 25 pi 25 pi
T a b l e  2:  R e a c t i o n  c o m p o n e n t  v a r i a t i o n s  1-3 w i t h  v a r i a b l e  v o l u m e s  a n d  c o n c e n t r a t i o n s  o f  c D N A .
For every real-time PCR reaction two important plots were generated: the 
amplification plot and the melting curve. As the PCR program is taking place the 
M astercycler ep Realplex4 reads the fluorescence emitted from each reaction in real time 
and plots the amount o f  fluorescence verses either cycle number or time, for the 
amplification plot and subsequent generation o f  the melting curve (described be low ).
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The amplification plot shows the fluorescence \e rsu s  number o f  cycles. Real­
time PCR products amplify in a particular manner, with three phases: exponential, linear 
and plateau (Figure 6). First, the exponential phase shows an increase in fluorescence in 
an exponential fashion, because no reagents are limiting at this point. The am ount o f  
fluorescence or PCR product can be associated with the starting number o f  inRNA 
transcripts (Yuan et al. 2006). With increasing cycles the PCR product increase is seen in 
a linear fashion, followed by a decline in the rate o f  increase (reagents are limiting) in the 
plateau phase (Yuan et al. 2006). Each amplification plot has a threshold level calculated 
by the software. We chose the default setting called the Noise Band, where the threshold 
level w as calculated to be 10 standard deviations above the noise o f  the baseline (found 
in Mastercycler ep R ealplex4 manual by Eppendorf). The threshold level in Figure 6 is 
indicated with a bold horizontal line. The fluorescence o f  any sample crosses the 
threshold level at a particular cycle number during the exponential phase. The cycle 
num ber at which the threshold level is crossed is called the Ct value (Figure 6). The 
lower the Ct value is the more efficient the reaction parameter. A lower Ct value can also 
mean that there were a higher number o f  mRN A  transcripts at the beginning o f  the 
reaction in samples (if  the primers o f  a particular gene product were already optimized). 
Each reaction was set up in triplicate; thus, another aspect to consider is reproducibility. 
One has more confidence in choosing the optimal parameter based on lowest Ct value 
plus highest reproducibility.
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Figure 6: Amplification plot for real-time PCR reactions
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F i g u r e  6:  T h e  M a s t e r c y c l e r  e p  R e a l  p i  e x 4 r e a d s  t he  l o g  t r a n s f o r m e d  f l u o r e s c e n c e  e m i t t e d  f r o m  e a c h  r e a c t i o n  
in r eal  t i m e  a n d  p l o t s  t h e  a m o u n t  o f  f l u o r e s c e n c e  v e r s e s  c y c l e  n u m b e r  in t h e  a m p l i f i c a t i o n  plot .  T h e  
t h r e s h o l d  l eve l  is i n d i c a t e d  w i t h  a b o l d  h o r i z o n t a l  l ine.  T h e  C t  v a l u e  is d e f i n e d  as  t h e  c y c l e  n u m b e r  in 
w h i c h  f l u o r e s c e n c e  o f  r e a c t i o n  p r o d u c t s  c r o s s e s  t h e  t h r e s h o l d  level .  T h e  t h r e e  p h a s e s  ( e x p o n e n t i a l ,  l i n e a r  
a n d  p l a t e a u )  a r e  a l s o  i n d i ca te d .
M elting curves were plotted by taking the first derivative o f  the dissociation curve 
by the software (generated by plotting fluorescence versus increasing temperature, 
causing the DNA to dissociate over time) and plotting this against temperature (Figure 7). 
The melting curve shows a spike indicating the temperature at which the amplified DNA 
dissociates. The temperature at which each PCR product dissociates is dependent upon 
its size and CG content. GFAP, S I 00, Vimentin and GAPDH PCR products are nearly 
the same size, so the higher the CG content o f  the PCR product the higher it's melting 
temperature. Typical PCR product melting temperatures are relatively high and one peak 
should be seen in the melting curve (80-90°C). In contrast, primer dimer melting 
temperatures are relatively low (~60-75°C). I f  there is more than one peak, more than 
one PCR products are being amplified. Therefore, if  there are primer dimers forming in
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reactions at certain temperatures, the melting curve will reflect their presence. This is 
another factor that needs to be considered when evaluating the results o f  optimization. 
Overall, low' Ct plus high reproducibility, along w ith a single peak in the melting curve, 
equals the optimal parameters (or “best results"). The optimal parameters found at each 
step in optimization were used in subsequent optimization steps.
Figure 7: M elting curve for real-time PCR reactions
1
1
60 62  64 6 8  70 72 7 ^  76 BO 82 && 86 ciB OQ 02 04
T em peratu re  [’C]
F i g u r e  7: T h e  m e l t i n g  c u r v e  is p l o t t e d  b y  t a k i n g  t h e  f i rs t  d e r i v a t i v e  o f  t h e  d i s s o c i a t i o n  c u r v e  a n d  p l o t t i n g  
t h a t  v e r s u s  t e m p e r a t u r e .  T h i s  s h o w s  w h i c h  t e m p e r a t u r e  t h e  D N A  a m p l i f i e d  in t h e  r e a c t i o n  d i s s o c i a t e s .
Tem perature optimization
Suggestions for temperature optimization w ere found in “Optimization o f  the new’ 
Lam bda Primers-Gradient PCR" (Eppendorf)- A gradient o f  annealing temperatures w as 
set up across the 12 columns o f  a plate layout (Table ?). Each reaction w as identical, and 
each temperature had triplicate reactions plus one No Template Control (NTC). Each 
gene was tested for best results using the same sample cDNA and same temperature 
gradient found in identical PCR programs. Each PCR program started w ith an initial 5 
minutes at 95°C to activate the DNA polymerase in the SYBR Green QuantiFast M aster
Mix. This is followed by 40 cycles o f  denaturing (95°C) for 15 seconds, annealing 
(gradient as indicated by Table 3) for 15 seconds and extension (72°C) for 20 seconds. 
After amplification, the reactions were subjected to melting curves. The annealing 
temperature that gave the "best results" was used in subsequent optimization.
Table 3:Gradient of annealing temperature optimization used for GAPDH and astrocyte- 
specific genes
Well Position 1 | 2 2> 4 5 6 7 8 9 10 11 12
Annealing
Temperature
Celsius
49.9 50.2 50.9 52.0 53.4 54.9 56.5 58.1 59.5 60.7 61.6 62.0
T a b l e  3: T h e  g r a d i e n t  o f  a n n e a l i n g  t e m p e r a t u r e s  a c r o s s  t h e  12 c o l u m n s  u s e d  to  o p t i m i z e  all  g e n e s
Prim er concentration optimization
Next, different combinations o f  final primer concentrations were optimized. 
Suggestions for primer optimization were found in "Optimization o f  the new; Lambda 
Primers-Gradient PCR/' (Eppendorf). All combinations o f  final upstream verses 
downstream primer concentrations are shown in Table 4: each combination was tested in 
triplicate. These triplicate reactions were set up by adding 1 pi o f  6.25 juM, 12.5 pM  and 
25 pM primer concentrations into the 25 pi reactions, which gave final concentrations o f  
250 nM, 500 nM and 1000 nM respectively (Table 5). A total o f  nine different 
combinations o f  upstream verses downstream final primer concentrations were examined 
for each gene. Next, NTC reactions were set up in triplicate for each 250/250, 500/500 
and 1000/1000 combinations. Each gene was tested for optimal results using the same 
sample cDNA. The primer concentration that gave the "best results" was used in 
subsequent standard or efficiency curves. Optimal parameters were found for each gene 
(Table 6).
Table 4: Matrix of final upstream verses downstream primer concentration
l ypstream primer  
concentrations
250 nM 500 nM 1000 nM
Downstream 250 nM 250/250 500/250 1000 250 j
primer
concentrations
500 nM 250/500 500/500 1000/500 T|
1000 nM 250/1000 500/1000 1000/1000
T a b l e  4: T h i s  m a t r i x  o f  f i na l  u p s t r e a m  v e r s e s  d o w n s t r e a m  p r i m e r  c o n c e n t r a t i o n  s h o w s  e a c h  c o m b i n a t i o n  
u s e d  f o r  all  e a c h  g e n e  d u r i n g  p r i m e r  o p t i m i z a t i o n .
Table 5: Reaction components used during primer concentration optimization
Reaction Components Volume and [Concentration]
pi o f  [cDNA] 1 pi [1:4]
SY B R  Green M aster Mix 12.5 pi
Up Stream Primer 1 pi [6.25 pM, 12.5 pM  or 25 pM l
Down Stream Primer 1 pi [6.25 pM, 12.5 pM or 25 pM]
R Nase-Free W ater 9.5 pi
Total 25 pi
T a b l e  5: E a c h  r e a c t i o n  w a s  set  up  u s i n g  t h e  s a m e  v o l u m e  o f  r e a c t i o n  c o m p o n e n t s .  T h e  c o n c e n t r a t i o n  o f  all 
r e a c t i o n  c o m p o n e n t s  w e r e  e q u a l  e x c e p t  fo r  u p s t r e a m  a n d  d o w n s t r e a m  p r i m e r  c o n c e n t r a t i o n s .  T h e s e  v a r i e d  
b e t w e e n  6 . 2 5 p M .  1 2 . 5 g M  a n d  2 5 p M ,
Table 6: Optimal parameters for each gene
G ene Optimal cDNA  
(uls and dilution)
Optimal Annealing  
Tempera ture(°C)
Optimal Final 
|Primer] UptDown
G FAP 1 pi [1:4] 53.5 250 nM: 500 nM
SI 00 l p l  [1:4] 58.0 500 nM: 1000 nM
Vimentin 1 pi [1:4] 53.5 500 nM: 1000 nM
GAPDH 1
.. . ____
l p l  [1:4] | 56.5 1000 nM: 1000 nM
f a b l e  6: R e s u l t s  o f  v o l u m e  a n d  j c D N A J .  t e m p e r a t u r e  a n d  [ p r i m e r ]  o p t i m i z a t i o n  f o r  e a c h  g e n e .
Standard and efficiency curves
Standard curves are important for determining PCR efficiency and are done for 
standard or reference genes (i.e., GAPDH). Efficiency curves are essentially equal to
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standard curves, but are done for all experimental genes. Each standard and efficiency 
curve was done twice: once for a cDNA sample from the wild type animals and then for 
cDNA from Pde6b- animals. Five 10-fold serial dilutions were prepared from the cDNA 
stock (considered to be the lx  concentration); reactions were carried out in triplicate for 
each dilution. These curves were plotted as Ct versus Log2 [cDNA], which can be used to 
estimate the efficiency o f  each PCR product being amplified (Yuan et al., 2006). 
Theoretically, the num ber o f  PCR products should be doubled each amplification cycle, 
which would lead to percent amplification efficiency (PAE) equal to 100% (Yuan et al., 
2007). This would correspond to amplification efficiency (AE) o f  2, calculated by the
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equation 2  ' ' (Yuan et al., 2007). The reality o f  AE and PAE for a given sample is that 
they may not be optimal, depending on a number o f  criteria: optimal [primer], optimal 
annealing temperature, pipetting error, etc. (Yuan et al., 2007). PAE was found for every 
gene by taking the -(s lope) o f  the regression line fit to the curve data for that gene.
The regression line should have a slope close to -1 and a high r squared value, 
where PAE = -(s lope) (Yuan et al. 2007). These regression lines w:ere then tested for 
significance based on two criteria. First, the slope o f  each line should not be significantly 
different from -1 .  Second, the Pde6b- and Pde6b+ lines should not be significantly 
different from each other for the same gene (Yuan et al. 2006). If  both o f  these criteria 
were met, the efficiency v alues were accepted to be optimal. If  these criteria were not 
met, the value for PAE w as used as a correction term for the raw data.
Prior to each reaction set up, a Plate layout and PCR program was set up 
according to the Mastercycler R ealplex4 manual (Eppendorf). Next, a master mix was 
made for the 15 reactions (3 reactions per [cDNA]). The tube for the reaction mix was
labeled, wrapped in aluminum foil, and placed on ice. The reaction master mix was made 
by adding 187.5 pi o f  SYBR Green Master Mix. 142.5 pi RNase-free Sterile Water. 15 pi 
upstream primers, and 15 ul downstream primers together and mixed by pipetting up and 
down. This mixture was kept on ice while adding 1 pi o f  the appropriate [cDNA] to each 
well. 24 pi o f  the reaction master mix was then added to each well and mixed by 
pipetting up and down (Note: the tube was held with thumb and index finger near the top 
o f  the tube to keep the reaction mix from warming up). Strip caps were placed over 
reaction wells and w iped off with a Kim wipe. This plate o f  reactions was then placed in 
the Mastercycler Realplex  , the lid closed, and the PCR program initiated.
At the end o f  the reactions the data for each curve were then prepared for 
evaluation. Triplicate data were collected and only one value was needed, so the mean 
was taken o f  the closest two Ct values (within one amplification cycle), leaving one value 
for each [cDNA]. These data (see Appendix 1) were next analyzed using SPSS by simple 
linear regression models and 95% confidence intervals (Syntax found in Appendix 3) to 
test if  the slopes o f  the lines were the same as -1, and to test if  the lines for each gene are 
the same between genotypes (Output found in Appendix 2). If  the slopes o f  these lines 
are significantly different from -1 and significantly different from each other, a correction 
factor, PAE, should be used in subsequent analysis.
Real-time PCR procedure for individual runs
All cDNA samples (1:4 concentration) were subjected to identical real-time PCR 
for each gene in triplicate. 1.5 ml microcentrifuge tubes were labeled for each gene as a 
master mix tube, wrapped in tin foil and placed on ice in the hood. Pipettes, pipette tips, 
ultra clear strip caps, empty master mix tubes (on ice) and waste container was placed in
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the hood and sterilized by turning on the L’V light for 15 min. The reagents were 
prepared by centrifuging the primers, cDNA and SYBR green (wrapped in aluminum 
foil). Next, the primers and SYBR green were vortexed for 15 seconds, then gently 
tapped on the counter top to move all liquid to the bottom o f  the tubes.
Appropriate real-time PCR programs were constructed on M astercycler Realp /ex4. 
These PCR programs were similar to previous programs (Figure 7), but they had a 
specific temperature gradient so that all four genes could be run together (Table 7), with 
each subjected to their optimal annealing temperature. Two cDNA samples wrere run 
together: one Pde6b+ and one Pde6b- (Figure 8). I was kept blind to the age and 
genotype o f  all animals, so Dr. Jarvinen told me which pairs o f  cDNA samples to run 
together. (Note that for regular maintenance the computer was restarted for 10 minutes 
after several Real-time PCR runs).
Table 7:Gradient of annealing temperatures used for data collection runs
Column
Number
1 2 -■> 4 5 6 7 8 9 10 11 12
Annealing
Temperature
Celsius
53.4 53.5 56.5 58.1
T a b l e  7: A  g r a d i e n t  w a s  u s e d  f o r  a n n e a l i n g  t e m p e r a t u r e s  r e s u l t i n g  in t h e  o p t i m a l  a n n e a l i n g  t e m p e r a t u r e  f o r  
e a c h  g e n e  in t h e  w e l l s  i n d i c a t e d  a b o v e  ( c o l u m n  1: G F A P :  c o l u m n  2:  V i m e n t i n ;  c o l u m n  8; G A P D H  a n d  
c o l u m n  12: S I 0 0 ) .  O n l \  r e l e v a n t  t e m p e r a t u r e s  a r e  i n d i c a t e d .
The Plate layouts were created next. Three wells were chosen, labeled as 
appropriate (unknown or standard, Name: Gene name + cDNA and Target 1: Gene) for 
each gene and cDNA sample, and grouped as replicates. These fdes were saved as assays 
with appropriate information in the saved name (cDNA samples used, Run # and Date).
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The reactions were set up by adding the following to each tube: 58 pi RXuse Iree 
water, 75 pi Quantifast SYBR Green, 6 pi Up stream primer and 6 pi Down stream 
primer (new pipette tips were used for each amount o f  reagent added). The master mix 
tubes w^ere centrifuged at maximum speed for 30-45 seconds to mix and placed back on 
ice. Next, 1 pi o f  1:4 cDNA was added to wells for each gene in triplicate (6 wells total) 
(Figure 8 step 1). This was repeated for the 2nd cDNA (12 wells total) (Figure 8 step 2). 
Precautions as described for standard and efficiency curves were also followed here. 
Then 24 pi o f  master mix w ere added to each well for the appropriate gene (Figure 8 
steps 3-6) using a new tip for every addition and pipetting up and down several times to 
mix reactions well.
Figure 8: Real-time PC R  reaction set up in a 96-well plate for individual runs
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F i n u r e  8: T h i s  d r a w i n g  r e p r e s e n t s  t h e  9 6  w e l l  p l a t e  a n d  t h e  e x a c t  set  up  f o r  e a c h  o f  t h e  r e a l - t i m e  P C R  r uns .  
T h e  n u m b e r s  i n d i c a t e d  h e r e  s h o w  t h e  o r d e r f s t e p  n u m b e r  f o r  t he  a d d i t i o n  o f  e a c h  r e a c t i o n  c o m p o n e n t  (as  
d e s c r i b e d  a b o v e ) .
When all reactions were ready, they were covered w-ith ultra clear strip caps. The 
plate w7as put into the Mastercycler Real p i ex4 and the strip caps were wiped with a Kim 
wipe. The lid was closed, the handle pulled down and the program was started when the
light on the Mastercycler Realplex4 turned green. When the reactions were com plete the 
data analysis was done.
Data analysis criteria
The data were obtained in triplicate. However, for subsequent analysis, only two 
data points w ere needed. Criteria w ere established to eliminate the outlier w ithout bias so 
that the best two Ct values would be kept. The criterion wras to accept the 2 closest o f  the 
triplicate values, as long as they w7ere wathin one amplification cycle. This becomes an 
accepted duplicate pair that is segregated into high and low Ct values (Ruigh and Ri.(m). If 
the data did not meet the criteria, they w^ere repeated more than once. Triplicates that 
wrere repeated had to meet the first criteria plus be reproducible. This m eant that at least 
two repeat triplicate reactions must meet the first criteria plus the average o f  those 
accepted duplicates must be wdthin one amplification cycle o f  each other. If  these two 
repeated accepted duplicates were not within one amplification cycle, another accepted 
duplicate was required. When three accepted duplicates were obtained, the median 
duplicate w as accepted at the valid Ct for that sample.
These data were then tested for correlation between same age and genotype for 
each gene. This study sampled Pde6b- and Pde6b+ mice at 10 different time points with 
three mice per time point (5 mice for each genotype for PND 100). The sample size was 
6 (or 10) for each age. We expected that the Ct values would be similar for all animals at 
the same age for the same gene. The outputs for each correlation test are found in 
Appendices 6-9 and the SPSS syntax is Appendix 10.
Next, the data were analyzed using a relative quantification method called ACt. 
This method takes the difference between Ct values o f  the target (astrocytes-specific) and
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reference (GAPDI1) genes, which compares the expression o f  the target and reference 
gene (Yuan et al., 2006). The ACt method uses the equation: ACt = Ct iar^ i -  Ct[<C|UCM_. 
I Iere, the reference gene Ct value was always lower than the target gene Ct value. This is 
because number o f  mRNA molecules is always higher for the reference gene, GAPDH. 
The average ACt was then taken for the three values in each unique genotype/age. Next, 
each gene 's  ACt values v/ere plotted versus age for both genotypes. This gave two lines 
for each gene: Pde6b- verses Pde6b+. Thus, our gene expression can be interpreted 
easily between genotypes.
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C hapter  Three: Results
Standard and efficiency curves anal} sis
The standard and efficiency curves were tested using a simple linear regression 
analysis and confidence intervals (shown in Graph 2). Remember, we are trying to find 
out if  the slopes o f  these lines are significantly different from -1 and if  the lines for each 
gene are significantly different between genotypes. It was found (regression analysis 
syntax 3) that the Pde6b- lines were not significantly different from the Pde6b+ lines for 
any gene indicated by insignificant P values (P > 0.05) (Table 8). Confidence intervals 
were used to test if the slopes o f  each o f  the regression lines were the same or different 
from -1. If the confidence intervals included -1, there w as statistical evidence in fav or o f  
the hypothesis that the slope is equal to -1 for that genotype. If  the confidence intervals 
did not include -1, there was evidence that the slope was different from -1 for that 
particular genotype. It was found that the slopes o f  each o f  the regression lines were not 
significantly different from -1 with the exception o f  GFAP and vimentin for Pdebb- mice 
(Table 8). Although this was found, PAF will not be used in subsequent analysis. The 
rational behind this decision will be discussed later.
Raw data analysis using correlation
Ct data were subjected to a correlation test. Remember, each age o f  mice had a 
sample size o f  6 (3 Pdebb- and 3 Pde6b+), or 10 for PND 100. The high and low Ct 
values for each mouse o f  the same age were plotted together on a scatter plot, w here the 
X value was the high Ct and the Y value was the low Ct. All o f  the high and low Ct 
v alues for the mice o f  the same age correlated significantly; ever} correlation model had
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high r values and showed significant correlation at the 0.01 level, with the exception of 
two groups with significance at the 0.05 level and one group with marginal significance 
(where P = 0.58 for GAPDH at PND 42) (Table 9). These results indicate that we have 
found valid high and low Ct values from each o f  the mice at each age.
Table 8: Regression analysis and confidence interval values
Gene Pde6b- mice Pde6b+ m ice P value
GAPDH -1.002 (-1.125, -0.878) -0.912 (-1.035,-0.788) 0.252
GFAP -0.548 (-0.872, -0.225) -0.854 (-1.178,-0.530) 0.154
S 1 0 0 -1.099 (-1 .421,-0 .778) -1.034 (-1.358,-0.713) 0.738
Vim entin -0.815 (-0.990, -0.640) -1.025 (-1.200,-0.850) 0.084
T a b l e  8: S l o p e  ( 9 5 %  c o n f i d e n c e  i n t e r v a l s )  a n d  P  v a l u e s  f r o m  r e g r e s s i o n  a n a l y s i s  a r e  s u m m a r i z e d  h e r e  f or  
e a c h  u n i q u e  a g e / g e n o t y p e .  C o n f i d e n c e  i n t e r v a l s  f o r  e v e r y  u n i q u e  g e n o t y p e / a g e  i n c l u d e  -1 w i t h  t he  
e x c e p t i o n  o f  t h e  b o l d  f a c e  v a l u e s  ( G F A P  a n d  v i m e n t i n  o f  P d e 6 b -  m i c e ) .  P v a l u e s  i n d i c a t e  t h e  l eve l  o f  
s i g n i f i c a n c e  f o r  t h e  s i m i l a r i t y  b e t w e e n  t h e  t w o  r e g r e s s i o n  l ine s  ( o n e  f o r  e a c h  g e n o t y p e )  f o r  e a c h  g e n e .  
E a c h  g e n e  s h o w e d  a  P v a l u e  h i g h e r  t h a n  0 . 0 5  i n d i c a t i n g  t h a t  t h e r e  is n o  s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  
r e g r e s s i o n  l in es  f o r  e a c h  g e n o t y p e .
ACt data analysis using parametric and non-parametric tests
The ACt data (Appendix 10) were subjected to analysis for differences in gene 
expression at various ages for each gene. Since there is a sample size o f  three for each 
unique genotype/age, a mean was taken. This left only one ACt value for wild type and 
retinal degeneration at every time point for each gene. These values were plotted over 
time for GFAP (Graph 3), S I 00 (Graph 4) and vimentin (Graph 5) so that each gene 's  
expression pattern changes over time between genotypes could be seen (syntax for 
graphing in Appendix 13).
Graph 2: Scatter plot o f  standard and efficiency curves with regression lines
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G r a p h  2: S t a n d a r d  a n d  e f f i c i e n c y  c u r v e s  f or  P d e 6 b -  a n d  P d e 6 b +  m i c e  w i t h  t h e i r  r e s p e c t i v e  r e g r e s s i o n  l ines  
f o r  e a c h  g e n e .  R e g r e s s i o n  a n a l y s i s  u s i n g  c o n f i d e n c e  i n t e r v a l s  s h o w s  t h a t  all l ines  a r e  n o t  s i g n i f i c a n t l y  
d i f f e r e n t  f r o m  - 1  a n d  l ines  o f  t h e  s a m e  g e n e  d o  no t  d i f f e r  f r o m  e a c h  o t h er .
Next, both parametric and non-parametric tests were done to examine for 
significant differences between the ACt values o f  each gene between genotypes for each 
age point. First, a parametric test was done (the T-test; syntax and output in Appendices 
I 1-12, respectively), followed by a non-parametric test (Kruskal-Wallis Test; syntax and 
output in Appendices 14-15, respectively). These tests gave identical results where 
significant differences were seen (Graphs 3-5). In fact, each significant difference seen at
Table 9: Correlation summary: rv a lu e s  and significance levels for each unique gene age
G e n e  P r o d u c t
Aize G F A P SI  0 0 V i m e n t i n  j G A P D H
P N D  7 . 9 9 9 . 97 2 . 9 9 0 .991
P N D  14 . 8 4 4 * * 9 1 | ** . 9 6 2 . 9 9 8
P N D  21 . 93 5 . 9 9 6 .961 .941
P N D  2 8 . 9 9 7 . 9 6 9 . 9 7 8 . 9 9 0
P N D  35 . 9 9 7 . 9 9 5 . 9 9 7 . 9 9 7
P N D  4 2 . 9 7 6 . 99 2 . 9 6 0 . 7 9 7 *
P N D  4 9 . 9 9 2 . 9 98 . 9 9 7 . 9 9 7
P N D  100 . 9 9 4 .991 . 9 9 0 . 9 9 7
P N D  140 . 9 8 4 .991 . 9 8 7 . 9 8 6
P N D  2 5 0 . 9 9 6 . 9 8 6 . 9 9 7 .991
T a b l e  9:  G F A P ,  v i m e n t i n ,  S I  0 0  a n d  G A P D H  r  v a l u e s  f o r  c o r r e l a t i o n  m o d e l s  d o n e  a t  e a c h  o f  t h e  10 a g e s  in
o u r  s t u d y .  A l l  d a t a  w e r e  f o u n d  t o c o r r e l a t e  s i g n i f i c a n t l y  at  t h e  0 . 01  l eve l  ( t w o - t a i l e d )  e x c e p t  f o r  t h o s e  
i n d i c a t e d  b y  a s t e r i s k s  ( **  C o r r e l a t e  s i g n i f i c a n t l y  a t  t h e  0 . 0 5  l eve l  ( 2 - t a i l e d ) ;  * C o r r e l a t i o n  is m a r g i n a l l y  
s i g n i f i c a n t  at  t h e  0 . 0 5 1 - 0 . 0 6  l eve l  ( 2 - t a i l e d ) ) .  T h e s e  r e s u l t s  i n d i c a t e  t h a t  w e  h a v e  f o u n d  v a l i d  h i g h  a n d  l ow 
C t  v a l u e s  f r o m  e a c h  o f  t h e  m i c e  a t  e a c h  a ge .
a given time for a given gene was in favor o f  higher gene expression in wild type 
animals. Therefore, less m RN A  transcripts were being expressed in retinal degeneration 
mice than in wild type mice. This means that it would take more amplification cycles for 
a particular gene to reach the threshold level in retinal degeneration mice compared to 
wild type mice. Graphically, this is seen by a higher ACt value for retinal degeneration 
mice compared to wild type mice at that time for that particular gene. GFAP expression 
at PND 7 and 49 was found to be significantly higher in wild type mice compared to 
retinal degeneration mice (Graph 3). S I 00 expression at PND 49 was significantly higher 
in wild type mice compared to retinal degeneration mice (Graph 4). Vimentin expression 
at PND 21 was found to be significantly higher in wild type mice than retinal 
degeneration mice (Graph 5). Thus, GFAP is expressed less in RD at PN D  7, Vimentin 
is expressed less in RD at PND 21, and both GFAP and S I 00 are expressed less in RD at 
PND  49 (Graphs 3-5).
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Graph 3: Mean G FAP ACt for wild type and retinal degeneration over time
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G r a p h  3:  M e a n  G F A P  A Ct  ( G F A P v C T )  w a s  t a k e n  f o r  e a c h  a g e  a n d  g e n o t y p e  a n d  p l o t t e d  t o g e t h e r  ( p l u s  
e r r o r  b ar s) .  S i g n i f i c a n c e  w a s  f o u n d  ( i n d i c a t e d  b y  a n a s t e r i s k )  f o r  d i f f e r e n c e s  in g e n e  e x p r e s s i o n  o f  G F A P  
b e t w e e n  g e n o t y p e s  o f  e a c h  a g e  g r o u p .  T w o  t e s t s  w e re  d o n e  to t es t  f or  s i g n i f i c a n t  d i f f e r e n c e s :  a p a r a m e t r i c  
( T - t e s t )  a n d  n o n - p a r a m e t r i c  ( K r u s k a l - W a l l i s  T e s t )  a n a l y s i s .  L e v e l s  o f  G F A P  m R N A  e x p r e s s i o n  w e r e  
s i g n i f i c a n t l y  h i g h e r  in w i l d  t \ p e  c o m p a r e d  t o  R D  m i c e  at  P N D  7 a n d  4 9 .  as  s h o w n  b y  t h e  m e a n  A G F A P  C t  
v a l u e s  at  t h e s e  t i m e  p o i n t s .  U n e q u a l  d i s t a n c e s  b e t w e e n  t i c k  m a r k s  a r e  i n d i c a t e d  b> s l a s h  m a r k s  ( ).
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Graph 4: Mean S100 ACt for wild type and retinal degeneration over time
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* S i g n i f i c a n t  at t h e  0 . 0 5  l eve l  ( 2- t a i l ed ) .
G r a p h  4:  M e a n  S I 0 0  A Ct  ( S l O O v C T )  w a s  t a k e n  f o r  e a c h  a g e  a n d  g e n o t y p e  a n d  p l o t t e d  t o g e t h e r  ( p l u s  e r r o r  
b ar s ) .  S i g n i f i c a n c e  w a s  f o u n d  ( i n d i c a t e d  b y  an a s t e r i s k )  f o r  d i f f e r e n c e s  in g e n e  e x p r e s s i o n  o f  S I 0 0  
b e t w  e e n  g e n o t y p e s  o f  e a c h  a g e  g r o u p .  T w o  t es t s  w e r e  d o n e  to test  f or  s i g n i f i c a n t  d i f f e r e n c e s :  a  p a r a m e t r i c  
( 7 - t es t )  a n d  n o n - p a r a m e t r i c  ( K r u s k a l - W a i l i s  T e s t )  a n a l y s i s .  L e v e l s  o f  S I 0 0  m R N A  e x p r e s s i o n  w a s  
s i g n i f i c a n t l y  h i g h e r  in w i ld t y p e  c o m p a r e d  t o R D  m i c e  at P N D  4 9 .  a s  s h o w n  by t h e  m e a n  AS 100 C t  v a l u e s  
at  t h i s  t i m e  po in t .  U n e q u a l  d i s t a n c e s  b e t w e e n  t i c k  m a r k s  a r e  i n d i c a t e d  by  s l a sh  m a r k s  (/.').
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Graph 5: Mean vimentin ACt for wild type and retinal regeneration over time
GHintyi-s 
wild t v | ^
re t in a l  d e p ^ r in r r i t io n
E r ro r  hors: +/-  I C E
* S i g n i f i c a n t  at  t h e  0 . 0 5  l eve l  ( 2 - t a i l e d ) .
G r a p h  5: M e a n  v i m e n t i n  A C t  ( V I M E N l N v C T )  w a s  t a k e n  f o r  e a c h  a g e  a n d  g e n o t y p e  a n d  p l o t t e d  t o g e t h e r  
( p l u s  e r r o r  b ar s ) .  S i g n i f i c a n c e  w a s  f o u n d  ( i n d i c a t e d  b y  a n  a s t e r i s k )  f or  d i f f e r e n c e s  in g e n e  e x p r e s s i o n  o f  
v i m e n t i n  b e t w e e n  g e n o t y p e s  o f  e a c h  a g e  g r o u p .  T w o  t es ts  w e r e  d o n e  to tes t  f o r  s i g n i f i c a n t  d i f f e r e n c e s :  a 
p a r a m e t r i c  ( T - t e s t )  a n d  n o n - p a r a m e t r i c  ( K r u s k a l - W a l l i s  T e s t )  a n a l y s i s .  L e v e l s  o f  v i m e n t i n  m R N A  
e x p r e s s i o n  w a s  s i g n i f i c a n t l y  h i g h e r  in w i l d  t y p e  c o m p a r e d  t o R D  m i c e  a t  P N D  2 1. as  s h o w n  by  t h e  m e a n  
v i m e n t i n  A C t  v a l u e s  at  t h i s  t i m e  p o i n t .  U n e q u a l  d i s t a n c e s  b e t w e e n  t i c k  m a r k s  a r e  i n d i c a t e d  b y  s l a s h  m a r k s  
(//).
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Chapter  Four: Discussion  
Raw data analysis
W e used astrocyte-specific genes to examine changes in expression in the visual 
cortex o f  Pde6b- (RD) and Pde6b+ (WT) mice. As mentioned previously, 28%  o f  the 
cells in the visual cortex are astrocytes. The results o f  the mean ACt analysis (parametric 
and non-parametric tests for significance) show that GFAP is expressed less in RD  mice 
at PN D  7, vimentin is expressed less in RD mice at PND 21, and both GFAP and S I 00 
are expressed less in RD mice at PND 49 (relative to W T in all cases)(Figure 9).
Figure 9: Pde6b- (RD) mouse behavior and gene expression time-line
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F i g u r e  9:  T i m e - l i n e  s u m m a r y  o f  a s t r o c y t e - s p e c i f i c  g e n e  e x p r e s s i o n  a n d  b e h a v i o r  c h a n g e s  s e e n  in P d e 6 b -  
m i c e .  S i g n i f i c a n c e  w a s  f o u n d  u s i n g  p a r a m e t r i c  a n d  n o n - p a r a m e t r i c  t es ts .  G F A P  is e x p r e s s e d  l es s  in R D  at  
P N D  7. v i m e n t i n  is e x p r e s s e d  less in R D  at P N D  2 1 .  a n d  b o t h  G F A P  a n d  S I 0 0  a r e  e x p r e s s e d  l es s  in R D  at 
P N D  4 9  ( b a s e d  o n  c o m p a r i s o n  t o P d e 6 b *  m i c e  d a t a )  ( i n d i c a t e d  a b o v e  t i m e  l ine) .  T h e s e  a g e s  a r e  o n  o r  n e a r  
r e l e v a n t  a g e s  P N D  2 1.  4 2  a n d  100 w h e n  i m p o r t a n t  a s p e c t s  o f  v i s i o n  a r e  lost  ( i n d i c a t e d  b e l o w  t i m e  l ine) .
The first time point to show a significant difference between W T and RD  mice 
was at PND 7, where GFAP expression is less in RD mice. This age was not o f  critical
importance from our behavioral studies, and is prior to mice opening their eyes at PND 
12 (Hooks and Chen.. 2007). Howev er. PND 7 is within the critical period for ocular 
dominance plasticity (ODP) in the visual cortex o f  mice (Hooks and Chen.. 2007). It w as 
found that OD columns are formed for the most pail prior to visual stimulation: neural 
connections are established before eye opening and refined in response to visual 
experience (Hooks and Chen., 2007). Pde6b+ mice show a relatively moderate level o f  
G FA P expression (Graph 3), which could help stabilize the neural connections already 
made in the OD columns o f  the visual cortex during normal development. Pde6b- mice, 
however, have a much lower level o f  GFAP expression and may be experiencing less 
than normal OD column development (i.e., a delay in ocular dominance column 
development). A delay in OD column development could explain why GFAP expression 
is low in Pdeb6- at PND 7, since the visual cortex in these mice at PND 7 might need to 
continue to be plastic. This is supported by our data show ing high expression o f  vimentin 
at PND 7 in Pdebb- mice (Graph 5). This delay in development is only for a short period 
and is followed by an increase in G FA P expression peaking at PND 28 (the peak o f  
ODP). An explanation for this rebound o f  GFAP expression in Pde6b- mice could be that 
the OD columns' development is complete and the neural connections made are being 
stabilized by GFAP-expressing astrocytes.
The second time point to show a significant difference between WT and RD mice 
was at PND 21. where v imentin expression is less in RD mice. This age is when rods are 
lost in Pde6b- mice (Marc et al.. 2003: Chang et al., 2002), and a low lev el o f  v imentin 
expression does not make sense. Over time we see that Pde6b- and Pde6b+ mice show 
relatively high levels o f  vimentin expression at PND 7 followed by decrease in
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expression by PND 14 (Graph 5). Vimentin expression in Pde6b+ mice then increases by 
PND 21 (Graph 5). which could be due to normal cues during developmental to increase 
plasticity. Vimentin expression in Pde6b- mice, on the other hand, continues to decrease 
until PND21, w hich could be explained by the loss o f  rod function by PND  21 (Graph 5). 
The normal developmental cues to increase plasticity in the visual cortex may not be 
present in the Pde6b- mice, which could block an increase in vimentin expression. 
Pde6b- vimentin expression does increase to wild type levels by PND 28 (Graph 5) 
possibly because the cue for an increase in vimentin expression came a week late.
The third time point to show a significant difference between W T and RD  mice 
was at PND 49. The behavioral tests suggest that PND 49 is immediately after visual 
acuity is lost (by PN D  42) and well before the ability to detect differences in light 
illumination lost (by PN D  -100). Thus, PND 49 is between two very important ages 
w here the mice are in the process o f  losing the function o f  their cones. This age is where 
our data show a decrease in gene expression for GFAP and S I 00. Rem em ber that GFAP 
and S I 00 expression are correlated, and these proteins are seen in mature astrocytes. At 
PND 49 cone function is degrading and the neural connections previously made with 
cones are most likely no longer useful. N ew  neural connections may be made by 
remodeling, which would require an increase in plasticity via an increase in vimentin 
expression. Vimentin expression is seen to increase from PND 42 to PND 100 (Graph 5). 
PND 49 is during cone degradation and one should expect an increase in plasticity so that 
the brain can remodel and this is reflected in our data.
These Pde6b- and Pde6b+ mice are going through many changes 
developmentally. It was hypothesized earlier that we would find astrocyte-specific gene
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expression pattern changes at PND 21, 42 and 100 in astrocytes o f  the visual cortex in 
our Pde61> inice compared to Pde6b+ mice. In summary, our data suggest that changes 
in gene expression are taking place in some way at PND 7, 21 and 49. Our hypotheses 
may not be fully supported at the specific ages we found to be important via behavioral 
tests; however, our data do suggest changes in gene expression at potentially relevant 
ages (PND 7, 21 and 49).
A lthough this data is important for developing further research plans, the data 
obtained here is limited. Ct values are reflecting relative mRNA expression levels in the 
visual cortex o f  the mice. This is not at the protein level, which is much more important 
to consider. Overall, the conclusions made here are important, they are not fully 
supported by the data because we measured m RN A  expression
The correlation tests support that the raw data obtained here were valid for each o f  
the mice at each age. Each set o f  data had a sample size o f  6. All sets o f  data showed 
significant correlation (high r values and significance at the 0.05 level), with the 
exception o f  one marginally significant group (G APD H  at PND 49) (Table 8), even with 
our small sample size. Again, these results indicate that we have found legitimate high 
and low Ct values from each o f  the mice at each age.
Standard and efficiency curves analysis
The main purpose for standard and efficiency curves is to be able to use these data 
for statistical treatments (Yuan et al. 2006). Each curve gives a measure o f  efficiency, 
which can be used to support the raw data obtained or used as a correction term. Many 
studies to date do not measure levels o f  efficiency (Yuan et al. 2006), and this can be
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problematic. The data measurement in real-time PCR is Ct, a measure obtained during 
the exponential phase o f  amplification. The Ct value is indirectly proportional to the 
num ber o f  m RN A  transcripts in a starting sample. If  the efficiency o f  gene A is 100% 
and the efficiency o f  gene B is 80%, this difference in efficiency will have an exponential 
effect on the fluorescence detected and, therefore, the Ct value. I will illustrate this with 
an example, in which one cDNA sample is used for genes A and B. This cD N A  has the 
same num ber o f  starting m RN A  transcripts, 10, for each gene. If  reagents were not 
limiting during the first 20 amplification cycles, then each reaction should increase 
exponentially at their respectiv e efficiency levels. At the end o f  20 cycles gene A, with 
an efficiency level o f  100%, now has 2 1'00 L>cles = 1,048,576 copies o f  gene product 
A. At the end o f  the same 20 cycles gene B, with an efficiency level o f  80%, now has 
2°  80 ~ ° cLs = 65,536 copies o f  gene produce B. This is only 6.25% o f  gene product A!
We also considered how efficiency impacts Ct. Returning to the above example, 
assume the gene product A fluorescence was high enough at 20 cycles to pass the 
threshold level, and it thus has a Ct o f  20. Gene product B has not crossed the threshold 
level yet. How- many cycles will it take for gene product B to reach a fluorescence
() 80 * ncomparable to 1,048,576 copies? To find this out we can set 1,048,576 equal to 2 
L' cll‘s, and solve for cycle number, n. Our Ct value for gene product B with an efficiency
value o f  80% is 25. Thus, an efficiency value o f  80% dramatically changed the Ct value 
for gene B, even though it started with an equal number o f  mRNA transcripts. This 
example clearly illustrates why efficiency values are important during statistical 
treatments.
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It was found that the standard and efficiency curves for each gene were not 
significantly different from each other. It was also found that the slopes o f  each line w ere 
not significantly different from -1. However, the small sample size casts these results 
into some doubt. There were only two different samples used to get the standard and 
efficiency data, one o f  each genotype o f  the same age (PND 100). With such a small 
sample size, the standard error skyrockets. This could beg the question “how could the 
slopes o f  these lines be different from -1?” With a slightly higher number o f  samples 
being used for the curve data, the seemingly different trends would most likely become 
significant. A good example o f  this can be seen in the efficiency curves o f  GFAP. These 
lines seem to show slopes that could be different from each other. I f  there w ere even a 
couple more samples indicating this pattern o f  difference betw'een the slopes o f  
regression lines o f  Pde6b- verse Pde6b+, there would most likely be a significant 
difference.
Finally, it would be a good idea to include at least one sample from each age and 
genotype for the standard and efficiency curves. This would take much more time and 
energy, but would give a better indication if  a correction factor should be used. Also, 
using a correction factor here would seem reasonable at another level. Our standard and 
efficiency curves w'ere measured from one age (PND 100). How could a correction term 
derived from one age be the representative for all other ages? In the future, standard and 
efficiency curves should be done for every age and genotype. This would test whether 
efficiency is high enough to accept the raw data or if  one age/genotype has lower PAH, it 
could be corrected for.
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Appendices
1) Data for standard and efficiency curve anal) sis
L ogB ase2
T rea tm en t G e n e cDNA cD N A m ean Ct m ean plustype interaction m inustype in teraction2
P d e 6 b  - GAPDH 0.0001 -13.29 33.22 0 0 1 -13.29
P d e 6 b  - GAPDH 0.001 -9.97 31 .07 0 0 1 -9.97
P d e 6 b  - GAPDH 0.01 -6.64 27.19 0 0 1 -6.64
P d e 6 b  - GAPDH 0.1 -3.32 23.49 0 0 1 -3.32
P d e 6 b  - GAPDH 1 0 20.36 0 0 1 0
P d e6 b  + GAPDH 0.0001 -13.29 31 .66 1 -13.29 0 0
P d e6 b  + GAPDH 0.001 -9 .97 29.48 1 -9.97 0 0
P d e 6 b  + GAPDH 0.01 -6.64 25.84 1 -6.64 0 0
P d e6 b  + GAPDH 0.1 -3.32 23.53 1 -3.32 0 0
P d e 6 b  + GAPDH 1 0 19.49 1 0 0 0
P d e 6 b  - GFAP 0.0001 -13.29 36.29 0 0 1 -13.29
P d e 6 b  - GFAP 0.001 -9.97 33.02 0 0 1 -9.97
P d e6 b  - GFAP 0.01 -6.64 33.08 0 0 1 -6.64
P d e 6 b  - GFAP 0.1 -3.32 30.84 0 0 1 -3.32
P d e6 b  - G FA P 1 0 28.27 0 0 1 0
P d e6 b  + G FA P 0.0001 -13.29 35.56 1 -13.29 0 0
P d e 6 b  + GFAP 0.001 -9.97 31.36 1 -9.97 0 0
P d e 6 b  + G FA P 0.01 -6.64 29.25 1 -6.64 0 0
P d e6 b  + GFAP 0.1 -3.32 29.18 1 -3.32 0 0
P d e6 b  + GFAP 1 0 22.46 1 0 0 0
P d e6 b  - S 1 0 0 0.0001 -13.29 36.8 0 0 1 -13,29
P d e6 b  - S 1 0 0 0.001 -9.97 33.21 0 0 1 -9.97
P d e 6 b * S 1 0 0 0.01 -6.64 29 .44 0 0 1 -6.64
P d e6 b  - S 1 0 0 0.1 -3.32 26.2 0 0 1 -3,32
P d e 6 b  - S 1 0 0 1 0 22.04 0 0 1 0
P d e 6 b  + S 1 0 0 0.0001 -13.29 36 .53 1 -13.29 0 0
P d e 6 b + S 1 0 0 0.001 -9.97 35.48 1 -9.97 0 0
P d e 6 b  + S 1 0 0 0.01 -6.64 32.92 1 -6.64 0 0
P d e 6 b  + S 1 0 0 0.1 -3.32 29.16 1 -3.32 0 0
P d e 6 b  + S 1 0 0 1 0 22.5 1 0 0 0
P d e 6 b  - Vimentin 0.0001 -13.29 37 .24 0 0 1 -13.29
P d e 6 b  - Vimentin 0.001 -9 .97 35.5 0 0 1 -9.97
P d e6 b  - Vimentin 0.01 -6.64 32.89 0 0 1 -6.64
P d e6 b  - Vimentin 0.1 -3.32 28 .87 0 0 1 -3.32
P d e6 b  - Vimentin 1 0 27.01 0 0 1 0
P d e6 b  + Vimentin 0.0001 -13.29 35.5 1 -13.29 0 0
P d e6 b  + Vimentin 0.001 -9.97 33.56 1 -9.97 0 0
P d e 6 b + Vimentin 0.01 -6.64 30.05 1 -6.64 0 0
P d e6 b  + Vimentin 0.1 -3.32 26.5 1 -3.32 0 0
P d e 6 b + Vimentin 1 0 22 1 0 0 0
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2) Regression analysis output for standard and efficiency curs es
Regression for Pde6b-
[ D«r.aSet 1 ] J: stats meeting SPSS f i l e s  5-28-2008' Data for st.d and E 
cuive analysis as of 5-27-2008.sav
Variables Entered/Removed*
G e n e  M odel
V ariables
E n tered
V ariab les
R em o v ed M ethod
GA PDH 1 interaction,
Log
B ase 2 c
DNA„
m ean , a
p lustype
E nter
G FA P 1 interaction,
Log
B ase 2 c
DNA_.
m ean , a
p lustype
E nter
S 1 0 0  1 interaction,
Log
B ase 2 c
DNA_
m ean ,
p lustype
Enter
Vim entin 1 interaction,
Log
B ase2 c
DNA_
m ean , ,  a
p lustype
E nter
a - All re q u e s te d  va riab les  en te red , 
b. D ep en d en t Variable: C t_ m ean
Model Summary
Gene Model R R Square
Adjusted 
R Square
Std. Error of 
the Estimate
GAPDH 1 ,996a .992 .988 .52966
GFAP 1 .959a .919 .879 1.39026
S100 1 .979a .958 .937 1.38076
Vimentin 1 ,992a .984 .976 .75205
a- Predictors: (Constant), interaction. LogBase2cDNA_mean, 
plustype
47
A N O V A b
Gene Model
Sum of 
Squares df Mean Square F Sia
GAPDH 1 Regression 205 421 3 68.474 244.077 .000*
Residual 1.683 6 .281
Total 207.105 9
GFAP 1 Regression 132.446 3 44.149 22.842 001a
Residual 11.597 6 1.933
Total 144.043 9
S100 1 Regression 259.546 3 86.515 45.379 ,000a
Residual 11.439 6 1.906
Total 270.985 9
Vimentin 1 Regression 208.685 3 69.562 122.991 ,000a
Residual 3.394 6 .566
Total 212.079 9
a Predictors: (Constant), interaction, LogBase2cDNA_mean,. plustype 
b - Dependent Variable: Ct_mean
Coefficients1
G e n e M odel
U n slan d a rd ized
C oeffic ien ts
S tan d a rd iz e d
C oefficien ts
t Stg.
95°= C o n fid e n ce  Interval for B
B Stri Error B eta Lower B ound U pper B ound
G APD H 1 (C o n stan t) 20 .4 0 9 .410 4 9 .7 5 5 .000 19 .405 2 1 .4 1 3
L og6ase2cD N A _.m ean -1 .002 .050 -1 .035 -19 .876 000 -1 125 - 878
p lu stype - 46 7 .580 -.051 -.805 .451 -1 .887 .952
in terac tion .090 .071 093 1.267 .252 - 084 .265
G FA P 1 (C o n stan t) 2 8 .6 5 7 1.077 2 6 .616 .000 26 022 31 291
L og B ase2 cD N A _ m ean -.548 .132 -.679 -4 .144 006 -.872 -.225
p lustype -4 .769 1.523 - 628 -3 132 .020 -8 .495 -1 .044
in terac tion -.306 187 -.378 -1 .633 154 -.763 152
S 100 1 (C o n s tan t) 22.231 1.069 2 0 .7 9 0 .000 19.615 24 848
Log B ase2cD N A _ m e an -1 .099 .131 -.993 -8 .367 .000 -1 421 - 778
p lustype 2 .212 1 512 .213 1 463 .194 -1 .488 5 913
in te rac tion 065 .186 059 .350 .738 - 390 520
V im enlm 1 (C o n stan t) 26  884 .582 46  158 .00 c 2 5 .4 5 8 2 8 .3 0 9
L o g 6 a se 2 cD N A _ m ea n - 815 .072 - 832 -11 393 .000 -.990 - 640
p lustype -4 171 .824 -.453 -5 .064 002 -6 .187 -2 .156
in terac tion - 209 .101 - 214 -2 068 .084 -.457 038
a D e p en d en t V ariab le. C t_ m ean
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Regression for Pde6b+
[ 7»<u t a S e r: i j .T : stats irieet. i r.a S?.8S files 5-28-20 08 Lata fc 
curve ciiiaiysi s  as of 5-27-2C08. sav
Variables Entered/RemovedP
Gene Model
Variables
Entered
Variables
Removed Method
GAPDH 1 interaction
2,
Log
Base2c
DNA_
mean,’ a
minustype
Enter
GFAP 1 interaction
2,
Log
Base2c
DNA_
mean, a
minustype
Enter
S100 1 interaction
2,
Log
Base2c
DNA_
mean, a
minustype
Enter
Vimentin 1 interaction
2,
Log
Base2c
DNA_
mean, a
minustype
Enter
a- All requested variables entered.
t>- Dependent Variable: Ct_mean
Model Summary
Gene Model R R Square
Adjusted 
R Square
Std. Error of 
the Estimate
GAPDH 1 ,996a .992 .988 .52966
GFAP 1 ,959a .919 .879 1.39026
S100 1 ,979a .958 .937 1.38076
Vimentin 1 ,992a .984 .976 .75205
a- Predictors: (Constant), interaction2, LogBase2cDNA_mean, 
minustype
A N O V A b
Gene Model
Sum of 
Squares df Mean Square F Sig.
GAPDH 1 Regression 205.421 3 68.474 244.077 .000"
Residual 1.683 6 .281
Total 207.105 9
GFAP 1 Regression 132.446 3 44.149 22.842 001a
Residual 11.597 6 1.933
Total 144.043 9
S100 1 Regression 259.546 3 86.515 45.379 ,000a
Residual 11.439 6 1.906
Total 270.985 9
Vimentin 1 Regression 208.685 3 69.562 122.991 ,000a
Residual 3.394 6 .566
Total 212.079 9
a- Predictors: (Constant), interaction2, LogBase2cDNA_mean, minustype
b. Dependent Variable: Ct_mean
Coefficients3
G e n e M odel
U n stan d a rd ized
C oefficients
S tan d a rd ized
Coefficients
t Sig
95°e C onfidence  Interval for B
B Std. Error Beta Lower B ound U pper B ound
GAPDH 1 (C onstan t) 19.942 .410 48 .616 .000 18.938 20 .945
L ogB ase2 cD N A _ m ean -.912 .050 -.941 -18.084 000 -1 .035 -.788
m inustype .467 .580 .051 .805 .451 - 952 1.887
in leraclion2 -.090 .071 -.093 -1 .267 .252 - 265 084
G FA P 1 (C o n s tan t; 23  887 1.077 22 .186 000 21 .2 5 3 26 .522
L og B ase2 cD N A ^m ean -.854 .132 -1 .057 -6 .454 .001 -1 .178 -.530
m inustype 4 .769 1.523 .628 3.132 .020 1.044 8.495
interaction2 306 187 .378 1.633 154 - 152 763
S 1 0 0 1 (C onstan t) 24 .444 1.069 22 .8 5 9 .000 2 1 .827 27 .060
L ogB ase2cD N A _m ean -1.034 .131 -.934 -7 .872 000 -1 .356 - 713
m inustype -2 212 1.512 -.213 -1 .463 ,194 -5 913 1 488
in teraction2 -.065 .186 -.059 -.350 .738 -.520 .390
Vim e n tm 1 (C onstan t) 2 2 .712 582 38 .996 .000 2 1 .287 24 137
LogB ase2cD N A ._m ean -1 .025 .072 -1 .046 -14.317 .000 -1 .200 -.850
m inustype 4 171 .824 4 53 5.064 .002 2 156 6 .187
interactic.o2 209 101 .214 2 066 .084 - 038 457
a  D ep e n d e n t V ariable: Ct _m ean
50
3) Syntax for regression analysis using SPSS
SORT CASES BY Gene .
SPLIT FILE 
LAYERED BY Gene .
GRAPH
/SCATTERPLOT(BIVAR)=LogBase2cDNA_mean WITH Ct_mean BY Treatment 
/M ISSING=LISTW ISE .
REGRESSION 
/M ISSING LISTWISE 
/STATISTICS COEFF OUTS Cl R ANOVA 
/CRITERIA=PIN(.05) POUT(.IO)
/NOORIGIN
/DEPENDENT Ct_mean
/METHOD=ENTER LogBase2cDNA_mean plustype interaction .
REGRESSION 
/M ISSING LISTWISE 
/STATISTICS COEFF OUTS Cl R ANOVA 
/CRITERIA=PIN(.05) POUT(.IO)
/NOORIGIN
/DEPENDENT Ct_mean
/M ETHO D-EN TER LogBase2cDNA_mean minustype interaction2 .
4) Data: high and low Ct values for each sample
( iAPDII (il AP S I00 Vimenlin
(ionol\  pe Aye hi nh low high lew high low high low
\ v r PND 7 21.52 21.48 3 f  15 30.67 3 1.34 31 23 2 7~ 69 26 95
W 1 RND 7 20 81 20.61 24.89 24.57 3 1.9 31.2 26.82 25 89
\ \ T PND 7 21.37 21.24 26.29 26.21 32.19 31.3 2741 26.8
RD PND 7 21.15 2111 31.91 31.48 31.03 30.57 26.71 26.33
RD PND 7 23.87 23.14 34.19 34.11 34.09 34.03 30 19 29.68
RD PND 7 23.16 22.85 35.38 35.19 33.29 33.22 27.84 27.24
WT PND 14 22.31 21 67 28.55 28.05 27,84 27.24 28 27.56
WT PND 14 20.81 20.48 27.81 27.13 26.49 26.08 26.13 25.85
WT PND 14 20.43 20.13 28.44 27.44 26.36 26.33 28.03 27.33
RD PND 14 20.37 20.01 28.71 28.29 26.49 26.42 27.6 27.5
RD PND 14 19.99 19.7 27.46 26.46 25.93 25.21 26.1 1 25.99
RD PND 14 20.49 20.09 27.03 27.02 26.96 26.75 25.84 25.07
WT PND 21 21.88 21.72 28.13 27.37 27.54 27.5 27.29 27.25
WT PND 21 21.27 21.15 27.91 27.79 26.68 26.55 26.58 26.1 7
WT PND 21 22.3 21.85 26.64 26.47 27.26 26.9 27.45 27.3
RD PND 21 21.44 20.73 2S.02 27.56 26.89 26.7 27.34 26.81
RD PND 21 22.9 22.77 27.98 27.84 29.85 29.7 29.87 29.77
RD PND 21 20.79 20.78 28 89 28.84 26.39 26.35 28.2 27.26
WT PND 28 20.2 19.99 27.9 27.58 26.51 25.56 26.29 2 6 .18
WT PND 28 20.63 20.54 27.66 27.24 26.98 26.88 25.26 24.85
WT PND 28 21.5 21.44 29.47 29.4 27 51 26.74 26.73 25.92
RD PND 28 24.45 23.54 28.44 28.32 29.96 29.8 28.2 27.79
RD PND 28 22.95 22.7 31.33 31 15 28.24 27.85 27.95 27.86
RD PND 28 21.48 21.42 26.34 26.25 27.08 27.02 27.93 27.7
WT PND 35 21.69 21.32 28.91 28.85 27.63 26.72 27.52 27.28
WT PND 35 23.33 23.21 29.59 29.42 29.64 28.93 28.3 27.87
WT PND 35 20.91 20.82 29.08 28.94 26.95 26.73 26.78 26.78
RD PND 35 20.61 20. i 7 28.18 27.82 28.96 28.93 30.48 29.74
RD PND 35 31.24 31.09 35.58 34.64 36.37 36.08 36.02 35.49
RD PND 35 23.91 22.95 33.41 33.16 30.92 30.15 31.44 3141
WT PND 42 21.84 21.79 29 88 29.71 28.09 27 88 28.77 28.74
W T PND 42 22.32 21.92 29.15 28.63 28.96 28.67 30.61 30.06
WT PND 42 21.67 21.39 28.41 28.37 27.25 26.92 28 66 27.75
RD PND 42 22.5 21.88 29.81 29.34 26.5 26.49 29.35 28.63
RD PND 42 21.77 21.39 28.51 28.47 27.93 27.64 27.79 27.01
RD PND 42 22.84 21 89 31.29 30.41 27.64 27.52 28.33 27.61
WT PND 49 20.33 20 27.45 26.62 25.31 25.24 25.82 25.59
WT PND 49 20.75 20.56 28.57 28.44 26.33 26.23 28.36 27.82
WT PND 49 23.94 23.66 30,65 29.67 28.89 28.82 31.12 30.31
RD PND 49 2 1.99 21.95 30.84 30.65 29.81 28.84 28.26 27.44
RD PND 49 23.61 23.38 35.43 34.87 30.04 29.39 31.24 30.34
RD PND 49 21.93 21.8 31.83 30.99 28.61 28 28.23 27.83
WT PND 100 19.15 19.05 27.79 27.6 25.27 24.3 24.51 24.45
WT PND 100 23.39 23.35 28.58 28.34 27.33 27.27 31.11 30.12
WT PND 100 24.95 24.59 32.75 32.23 31.16 30.84 30.3 30.24
RD PND 100 25.8 25.05 31.57 30.77 28 47 27.74 32.96 32.63
RD PND 100 20.8 20.65 27.03 26.37 26.96 26.02 ’’8 9^ 28.07
RD PND 100 21.97 32.24 31.3 29.95 29.86 28.91 28.1 7
WT PND 140 20.75 20.39 27.96 27.44 26.39 25.85 28 07 27 29
WT PND 140 2 1.2 20.71 27.86 27.11 26.81 2 6 4 5 25.99 25.56
WT PND 140 21.65 21.56 28.76 28.44 28.84 28.34 28.17 28 1
WT PND 140 22.75 21.85 30.52 30.27 27.77 27.5 26.87 26.68
W 1 PND 140 20.1 20 30.41 29.59 26.77 26.2 26 36 26 31
RD PND 140 23.13 23.08 29.29 28.81 28.35 28.32 27.47 27.2
RD PND 140 22.83 22.34 29.85 29.79 26.96 26 26 28.82 27.83
RD PND 140 22.93 22.58 31.01 30.75 28.39 28.3 30.81 30.34
RD PND 140 24.73 24.69 29.2 28.25 28.63 28.52 30.44 30.02
RD PND 140 24.58 24.38 32.85 32.27 31.91 31.45 31.45 30.58
W'T PND 250 21.4 20.76 30.95 30.34 26.89 26.76 25.87 25.71
WT PND 250 20.63 20.28 28.54 27.74 26.52 26.3 26.59 26.12
WT PND 250 19.98 19.98 25.37 25.28 26.72 26.26 27.57 27.42
RD PND 250 24.85 24.32 30.75 30.22 27.79 27.62 30.42 30.35
RD PND 250 19 89 19.86 32.62 31.78 26.75 25.78 27.92 27.78
RD PND 250 22.46 22.39 33.82 33.53 30.93 30.73 28.49 28.18
52
5) Correlation analysis syntax using SPSS
* W e split the file by Age so that SPSS will repeat everything we ask it to do for every level of 
Age: 7, 14, 21, etc.
SORT CASES BY Age .
SPLIT FILE 
SEPARATE BY Age .
* W e ran bivariate Pearson correlations between the high and low values for each mouse.
CO RRELATIONS 
A/ARIABLES=GAPDHhigh GAPDHlow 
/P R IN T-TW O TA IL  NOSIG 
/M IS S IN G -PA IR W ISE  .
CORRELATIONS 
/V A R IA B LE S - GFAPhigh GFAPlow 
/P R IN T-TW O TA IL  NOSIG 
/M ISS IN G -P A IR W IS E  .
CORRELATIONS 
/VARIABLES-S1 OOhigh SIOOlow 
/PRINT=TW O TAIL NOSIG 
/M IS S IN G -PA IR W ISE  .
CORRELATIONS
/VAR IABLES-V IM EN TlN high VIMENTINlow 
/P R IN T-TW O TA IL  NOSIG 
/M IS S IN G -PA IR W ISE  .
* W e produced scatterplots and later added the best fit straight lines through Chart Editor (by 
clicking on the graphs in the output).
GRAPH
/SCATTERPLOT(BIVAR)=GAPDHIow WITH GAPDHhigh 
/M ISS IN G -LIS TW IS E  .
GRAPH
/SCATTERPLOT(BIVAR)=GFAPlow WITH GFAPhigh 
/M ISS IN G -LISTW ISE  .
GRAPH
/SCATTERPLOT(BIVAR)-SIOOIow WITH SlOOhigh 
/M ISS IN G -LIS TW IS E  .
GRAPH
/SCATTERPLO T(BIVAR)-V IM ENTIN low  WITH VIMENTINhigh 
/M IS S IN G -LIS TW IS E  .
5 3
6) G F A P  SPSS correlation statistics
Output Created 
Comments
06-MAY-2008 13:35:28
Input Data F:\Research\GFAP\Current analysis 2-7- 
08\Latest analysis 041508*2008-05-01 Data 
Set.sav
Filter <none>
Weight <none>
Split File
N of Rows in Workinq Data 
File
Age
64
Missing Value Definition of Missing User-defined missing values are treated as
Handling missing.
Cases Used Statistics for each pair of variables are based 
on all the cases with valid data for that pair.
Syntax CORRELATIONS 
/VARIABLES=GFAPhigh GFAPiow 
/PRINT=TWOTAIL NOSIG 
/MISSING=PAIRWISE .
Resources Elapsed Time 0:00:00.00
[DataSetl] F:\Research\GFAP\Current analysis 2-7-08\Latest analysis 
041508X2008-05-01 Data Set.sav
Age = PND 7 GFAPhigh GFAPiow
GFAPhigh Pearson Correlation 
Sig. (2-tailed)
N
GFAPiow Pearson Correlation 
Sig. (2-tailed)
N
1 | .999(0 
.000 
6 6 
.999(0  i 1 
.000 
6 6
'* Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 7
Age = PND 14 GFAPhigh GFAPiow
GFAPhigh Pearson Correlation 
Sig. (2-tailed)
N
GFAPiow Pearson Correlation 
Sig. (2-tailed)
N
1 .8440 
.035 
6 6 
.8440 1
.035 •
6 6
* Correlation is significant at the 0.05 level (2-tailed), 
a Age = PND 14
Age =  PND 21 GFAPhigh GFAPiow
GFAPhigh Pearson Correlation 
Sig. (2-tailed)
N
GFAPiow Pearson Correlation 
Sig. (2-tailed)
N
1 .935(0 
.006 
6 6 
.935(0  1 
.006 
6 6
54
Correlation is significant at the 0.01 level (2-tailed.) 
a Age = PND 21
Age = PND 28 GFAPhigh GFAPiow
GFAPhigh Pearson Correlation 
Sig. (2-tailed)
N
GFAPiow Pearson Correlation 
Sig. (2-tailed)
N
1 .997(* *) 
.000 
6 6 
.997(**) 1 
.000 
6 6
Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 28
Age = PND 35 GFAPhigh GFAPiow
GFAPhigh Pearson Correlation 
Sig. (2-tailed)
N
GFAPiow Pearson Correlation 
Sig. (2-tailed)
N
1 , .9 9 7 D  
.000 
6 6 
.997(**) 1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 35
Age =  PND 42 GFAPhigh GFAPiow
GFAPhigh Pearson Correlation 
Sig. (2-tailed)
N
GFAPiow Pearson Correlation 
Sig. (2-tailed)
N
1 ,976(*‘ ) 
.001 
6 ' 6 
.9 7 6 D  ! 1 
.001 
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 42
Age =  PND 49 GFAPhigh - GFAPiow
GFAPhigh Pearson Correlation 
Sig. (2-tailed)
N
GFAPiow Pearson Correlation 
Sig. (2-tailed)
N
1 , .9 9 2 D  
.000 
6 6 
,992(**) 1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tailed),
a Age -  PND 49
Age = PND 100 GFAPhigh GFAPiow
GFAPhigh Pearson Correlation 
Sig. (2-tailed)
N
GFAPiow Pearson Correlation 
Sig (2-tailed)
N
1 ,994(*’ ) 
.000 
6 6 
.994(**) 1 
.000 
6 6
Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 100
Age = PND 140 GFAPhigh GFAPiow
GFAPhigh Pearson Correlation 1 .984(**)
Sig. (2-tailed) .000
N 10 10
GFAPiow Pearson Correlation .984(*‘ ) 1
Sig. (2-tailed) .000
N 10 10
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 140
Age =  PND 250 GFAPhigh GFAPiow
GFAPhigh Pearson Correlation 
Sig. (2-tailed)
N
GFAPiow Pearson Correlation 
Sig. (2-tailed)
N
1 .996(**) 
.000 
6 : 6 
,996(**) 1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 250
7) Vimentin SPSS correlation statistics
Output Created 06-MAY-2008 13:36:52
Comments
Input Data F:\Research\GFAP\Current analysis 2-7-08\Latest
analysis 041508X2008-05-01 Data Set.sav
Filter <none>
Weight <none>
Split File Age
N of Rows in Working Data 64
File
Missing Value Definition of Missing User-defined missing values are treated as
Plandling missing.
Cases Used Statistics for each pair of variables are based on
all the cases with valid data for that pair.
Syntax CORRELATIONS
/VARIABLES=Vimentinhigh Vimentinlow
/PRINT=TWOTAIL NOSIG
/MISSING=PAIRWISE .
Resources Elapsed Time 0:00:00.00
[DataSetl] F:\Research\GFAP\Current analysis 2 -/-08\Latest analysis 
041508X2008-05-01 Data Set.sav
5 6
Age = PND 7 VIMENTINhigh VIMENTINlow
VIMENTINhigh Pearson Correlation 
Sig. (2-tailed)
N
VIMENTINlow Pearson Correlation 
Sig. (2-tailed)
N
1 ,9S0i‘ N
.000
6 6 
.9900*) 1 
.000
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 7
Age = PND 14 VIMENTINhigh VIMENTINlow
VIMENTINhigh Pearson Correlation 
Sig. (2-tailed)
N
VIMENTINlow Pearson Correlation 
Sig. (2-tailed)
N
1 ,962(*‘ ) 
.002
6 6 
.962(**) 1 
.002
6 6
** Correlation is significant at the 0.01 level (2-tailed). 
a Age = PND 14
Age = PND 21
VIMENTIN !
high 1 VIMENTINlow
VIMENTINhigh Pearson Correlation 
Sig. (2-tailed)
N
VIMENTINlow Pearson Correlation 
Sig. (2-tailed)
N
1 .961 (**) 
.002
6 ; 6 
.961 (**) 1 
.002
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 21
Age =  PND 28
VIMENTIN
high VIMENTINlow
VIMENTINhigh Pearson Correlation 
Sig. (2-tailed)
N
VIMENTINlow Pearson Correlation 
Sig. (2-tailed)
N
1 , .978(**) 
.001
6 6 
.978('*) 1 
.001
6 6
** Correlation is significant at the 0.01 level (2-tailed),
a Age = PND 28
57
Age = PND 35 VIMENTINhigh VIMENTINlow
VIMENTINhigh Pearson Correlation 
Sig. (2-tailed)
N
VIMENTINlow Pearson Correlation 
Sig. (2-tailed)
N
1 ,997(**) 
.000
6 6 
997(” ) 1 
.000
6 6
** Correlation is significant at the 0.01 level (2-tailed) 
a Age = PND 35
Age = PND 42 VIMENTINhigh VIMENTINlow
VIMENTINhigh Pearson Correlation 
Sig. (2-tailed)
N
VIMENTINlow Pearson Correlation 
Sig. (2-tailed)
N
1 ,960(**) 
.002
6 6 
,960(*‘ ) 1 
.002
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 42
Age =  PND 49 VIMENTIN
high VIMENTINlow
VIMENTINhigh Pearson Correlation 
Sig. (2-tailed)
N
VIMENTINlow Pearson Correlation 
Sig. (2-tailed)
N
1 .997(” ) 
.000
6 6 
,997(“ ) , 1 
.000 :
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 49
Age = PND 100
VIMENTIN ,
high VIMENTINlow
VIMENTINhigh Pearson Correlation 
Sig. (2-tailed)
N
VIMENTINlow Pearson Correlation 
Sig. (2-tailed)
N
1 .990(*") 
.000
6 6 
,990(“ ) 1 
.000
6 6
** Correlation is significant at the 0.01 level (2-tailed),
a Age = PND 100
5 8
Age = PND 140 VIMENTINhigh VIMENTINlow
VIMENTINhigh Pearson Correlation 
Sig. (2-tailed)
N
VIMENTINlow Pearson Correlation 
Sig. (2-tailed)
N
1 ,987(**) 
.000
10 10 
,987(” ) 1 
.000
10 10
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 140
Age =  PND 250 VIMENTINhigh VIMENTINlow
VIMENTINhigh Pearson Correlation 
Sig. (2-tailed)
N
VIMENTINlow Pearson Correlation 
Sig. (2-tailed)
N
1 I ,997(**) 
.000
6 6 
,997(**) 1 
.000
6 6
*’ Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 250
8) S100 SPSS correlation statistics
Output Created 
Comments
06-MAY-2008 13:33:53
Input Data F:\Research\GFAP\Current analysis 2-7-08\Latest 
analysis 041508V2008-05-01 Data Set.sav
Filter <none>
Weight <none>
Split File Age
N of Rows in Working Data 
File 64
Missing Value Definition of Missing User-defined missing values are treated as missing.
Handling Cases Used Statistics for each pair of variables are based on all 
the cases with valid data for that pair.
Syntax CORRELATIONS 
/VARlABLES=S100high S100low 
/PRINT=TWOTAIL NOSIG 
/MISSING=PAIRWISE .
Resources Elapsed Time 0:00:00.09
[DataSetl] F :\Research\GFAP\Currenc analysis 2-7-uR\Laresc analysis 
04150812008-05-01 Data Set.sav
Age = PND 7 S1 OOhigh S100low
S100high Pearson Correlation 
Sig. (2-tailed)
N
SIOOlow Pearson Correlation 
Sig. (2-tailed)
N
1 .9 7 2 D  
.001 
6 6 
,972(**) 1 
.001 
6 6
Correlation is significant at the 0.01 level (2-tailed) 
a Age -  PND 7
Age = PND 14 SlOOhigh SlOOlow
SlOOhigh Pearson Correlation 
Sig. (2-tailed)
N
SlOOlow Pearson Correlation 
Sig. (2-tailed)
N
1 .9110 
.012 
6 6 
■911 (') 1 
.012 
6 6
Correlation is significant at the 0.05 level (2-tailed), 
a Age = PND 14
Age = PND 21 SlOOhigh SlOOlow
SlOOhigh Pearson Correlation 
Sig. (2-tailed)
N
SlOOlow Pearson Correlation 
Sig. (2-tailed)
N
1 .996(0 
.000 
6 6 
.996(0 1
.000 j
6 : 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 21
Age =  PND 28 SlOOhigh ! SlOOlow
SlOOhigh Pearson Correlation 
Sig. (2-tailed)
N
SlOOlow Pearson Correlation 
Sig. (2-tailed)
N
1 .969(0 
.001 
6 6 
.969(0 1 
.001 
6 6
Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 28
Age = PND 35 SlOOhigh SlOOlow
SlOOhigh Pearson Correlation 
Sig. (2-tailed)
N
SlOOlow Pearson Correlation 
Sig. (2-tailed)
N
1 .995(0 
.000 
6 6 
.995(0  1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tailed)
a Age = PND 35
60
Age = PND 42 SlOOhigh SlOOlow
SlOOhigh Pearson Correlation 
Sig. (2-tailed)
N
SlOOlow Pearson Correlation 
Sig. (2-tailed)
N
1 992(“') 
.000 
6 6 
,992(*') 1 
.000 
6 6
Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 42
Age =  PND 49 SlOOhigh SlOOlow
SlOOhigh Pearson Correlation 
Sig. (2-tailed)
N
SlOOlow Pearson Correlation 
Sig. (2-tailed)
N
1 ; .9 8 8 D  
.000 
6 6 
,988(**) ■ 1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 49
Age = PND 100 SlOOhigh SlOOlow
SlOOhigh Pearson Correlation 
Sig. (2-tailed)
N
SlOOlow Pearson Correlation 
Sig. (2-tailed)
N
1 .991 (**) 
.000 
6 6 
.991 ('*) 1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-taiied). 
a Age = PND 100
Age = PND 140 SlOOhigh S1 OOlow
SlOOhigh Pearson Correlation 1 ■991(*‘ )
Sig. (2-tailed) .000
N 10 10
SlOOlow Pearson Correlation .991 D 1
Sig. (2-tailed) .000
N 10 10
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 140
Age =  PND 250 SlOOhigh SlOOlow
SlOOhigh Pearson Correlation 
Sig. (2-tailed)
N
SlOOlow Pearson Correlation 
Sig. (2-tailed)
N
1 .9 8 6 D  
, .000 
6 ! 6 
.986(**) , 1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tailed).
6 1
a Age = PND 250
9) GAPDH SPSS correlation statistics
Output Created 06-MAY-2008 13:36:09
Comments
Input Data F:\Research\GFAP\Current analysis 
2-7-08\Latest analysis 041508\2008- 
05-01 Data Set.sav
Filter <none>
Weight <none>
Split File Age
N of Rows in Working
64Data File
Missing Value Definition of Missing User-defined missing values are
Handling treated as missing.
Cases Used Statistics for each pair of variables are 
based on all the cases with valid data 
for that pair.
Syntax CORRELATIONS 
A/ARIABLES=GAPDHhigh 
GAPDHlow 
/PRINT=TWOTAIL NOSIG 
/MISSING=PAIRWISE .
Resources Elapsed Time 0:00:00.00
[DataSetl] F: \ Research\GFAP\Current analysis 2-7-08\Lat.est analysis 
041508X2008-05-01 Data Set.sav
Age = PND 7 GAPDHhigh . GAPDHlow
GAPDHhigh Pearson Correlation 
Sig. (2-tailed)
N
GAPDHlow Pearson Correlation 
Sig. (2-tailed)
N
1 .991 (**) 
.000 
6 , 6 
.991 (**) ' 1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 7
Age = PND 14 GAPDHhigh GAPDHlow
GAPDHhigh Pearson Correlation 
Sig. (2-tailed)
N
GAPDHlow Pearson Correlation 
Sig. (2-tailed)
N
1 ,998(**) 
.000
6 : 6 
.9 9 8 D  1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 14
62
Age = PND 21 GAPDHhigh GAPDHlow
GAPDHhigh Pearson Correlation 
Sig. (2-tailed)
N
GAPDHlow Pearson Correlation 
Sig. (2-tailed)
N
1 .941 (**)
.005
6 6 
.941C*) 1 
.005
6 6
Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 21
Age = PND 28 GAPDHhigh GAPDHlow
GAPDHhigh Pearson Correlation 
Sig. (2-tailed)
N
GAPDHlow Pearson Correlation 
Sig. (2-tailed)
N
1 .990(‘ *) 
.000 
6 6 
.990(“ ) 1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tatled). 
a Age = PND 28
Age = PND 35 GAPDHhigh GAPDHlow
GAPDHhigh Pearson Correlation 
Sig. (2-tailed)
N
GAPDHlow Pearson Correlation 
Sig. (2-tailed)
N
1 997(*‘ ) 
.000 
6 6 
.997(") 1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 35
Age =  PND 42 GAPDHhigh GAPDHlow
GAPDHhigh Pearson Correlation 
Sig. (2-tailed)
N
GAPDHlow Pearson Correlation 
Sig. (2-tailed)
N
1 .797 
.058 
6 6 
.797 i 1
.058
6 6
a Age = PND 42
Age =  PND 49 GAPDHhigh GAPDHlow
GAPDHhigh Pearson Correlation 
Sig. (2-tailed)
N
GAPDHlow Pearson Correlation 
Sig. (2-tailed)
N
1 ,997(**) 
.000 
6 6 
,997(**) 1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 49
63
Age = PND 100 GAPDHhigh GAPDHlow
GAPDHhigh Pearson Correlation 
Sig. (2-tailed)
N
GAPDHlow Pearson Correlation 
Sig. (2-tailed)
N
1 .997(") 
.000 
6 6 
.997(**) 1 
.000 
6 6
Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 100
Age =  PND 140 GAPDHhigh GAPDHlow
GAPDHhigh Pearson Correlation 1 .986(**)
Sig. (2-tailed) .000
N 10 ' 10
GAPDHlow Pearson Correlation ,986(“ ) 1
Sig. (2-tailed) .000
N 10 10
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 140
Age = PND 250 GAPDHhigh GAPDHlow
GAPDHhigh Pearson Correlation 
Sig. (2-tailed)
N
GAPDHlow Pearson Correlation 
Sig. (2-tailed)
N
1 : .991 (**) 
.000 
6 6 
.991 (**) ; 1 
.000 
6 6
** Correlation is significant at the 0.01 level (2-tailed), 
a Age = PND 250
64
10) Data: ACt values
Animal Genotype Age
Wild ty pe P M )  7
W ild ly pe I’M )  7
Wild type I 'M )  7
Retinal degeneration P M )  7
Retina! degeneration I’M )  7
Retinal degeneration P M )  7
Wild ty pe P M )  14
Wild l\ pe PND 14
Wild type P M )  14
Retinal degeneration PND 14
Retinal degeneration PND 14
Retinal degeneration PND 14
W ild type PND 21
W ild type PND 21
Wild type PND 21
Retinal degeneration PND 21
Retinal degeneration PND 21
Retinal degeneration PND 21
Wild type PND 28
Wild type PND 28
Wild type PND 28
Retinal degeneration PND 28
Retinal degeneration PND 28
Retinal degeneration PND 28
W ild type PND 35
Wild type PND 35
Wild type PND 35
Retinal degeneration PND 35
Retinal degeneration PND 35
Retinal degeneration PND 35
W ild type PND 42
W ild type PND 42
Wild lype PND 42
Retinal degeneration PND 42
Retinal degeneration PND 42
Retinal degeneration PND 42
Wild l>pe PND 49
Wild type PND 49
Wild ly pe PN D  49
Retinal degeneration PND 49
Retinal degeneration PND 49
Retinal degeneration PND 49
W ild ly pe PND 100
W ild type PND 100
Wild ty pe PND 100
Retinal degeneration PND 100
Retinal degeneration PND 100
Retinal degeneration PND 100
W ild type PND 140
Wild type PND 140
Wild type PND 140
Wild type PND 140
W lId type PND 140
Retinal degeneration PND 140
Retinal degeneration PND 140
Retinal degeneration PND 140
Retinal degeneration PND 140
Retinal degeneration PND 140
Wild ty pe PND 250
Wild type PND 250
Wild type PND 250
Retinal degeneration PND 250
Retina) degeneration PND 250
Retinal degeneration PND 250
NOS 100 \(7l Yimcnim
9.79 5 82
10 84 5.65
10 44 5.8
9 67 5 39
10 55 6 43
10.25 4.53
5.55 5.79
5 64 5.34
6.07 7.4
6.27 7.36
5.72 6 2
6.57 5.17
5.72 5.47
5 41 5.17
5 5.3
5.71 5.99
6.94 6.98
5 58 6.94
5.94 6.14
6.34 4.47
5.66 4 86
5 88 4
5 22 5.08
5 6 6.37
5.67 5.89
6.02 4 82
5.97 5 91
8 56 9.72
5.06 4.59
7.1 1 8
6 17 6 94
6.7 8.22
5.56 6.68
4.31 6 8
6 21 5.82
5 21 5.6
5.1 1 5.54
5.62 7.43
5.06 6 92
7.36 5.88
6.22 7.29
6.44 6 16
5.69 5 3 8
3 93 7.25
6.23 5.5
2.68 7.37
5 76 7.77
7 8 6.43
5 55 7.11
5.67 4 82
6 98 6 53
5.34 4.48
6 44 6 29
5.23 4 23
4.02 5 74
5.59 7 82
3.87 5.52
7.2 6.54
5.75 4.71
5.95 5 9
6.51 7.52
3.12 5 8
6 39 7.97
8.4 5.91
\ t  ( <ilM»
9 4!
4 (12
4 94
10.57
] 0 64
12 28
6.31
6 82
7 66
8.31
7.11
6 74
5 95
6.64
4 48
6 7
5.07
8.08
7.64
6 86
7 07
4.58
8.41
4 85
7.37
6 24
8.14
7.61
3.94
9 86
7.98
6.77
6 86
7.39
6.91
8.48
6 87
7.85
6 36
8 78
11.65
9.54
8 6
5.09
7.72
5 74
5 97
9.66
7.15
6 53
6 .9 9
8.1
9.95
5 94
7.23
8 . 12
4 02
8 08
9.57
7.68
5.35
5 9
12.32
1 I 25
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11) \C t  t-(est analysis syntax using SPSS
‘ W e run the analysis seperately for each time point. Start by splitting the file by Age again. 
SORT CASES BY Age .
SPLIT FILE 
SEPARATE BY Age .
T-TEST 
GROUPS = Genotype(1 2)
/M ISSING = ANALYSIS
/VARIABLES = GFAPvCT SIOOvCT VIMENTINvCT 
/CRITERIA = C I(.95) .
12) T-test output each gene/age using SPSS  
T-Test
[DataSetl] C:\Documents and Settings\arieck\Local Settings\Temporary Internet 
Files\Content.IE5\Q5U5I1K3\200 8 - 0 5 -01%20Data%2OSet[1] .sav 
Age = PND 7
Group Statistics1
Genotype N Mean Std. Deviation
Std. Error 
Mean
GFAPvCT Wild type 3 6.1233 2.88327 1.66466
Retinal degeneration 3 11.1633 .96769 .55870
SIOOvCT Wild type 3 10.3567 .52994 .30596
Retinal degeneration 3 10.1567 .44736 .25828
VIMENTINvCT Wild type 3 5.7567 .09292 .05364
Retinal degeneration 3 5.4500 .95142 .54930
a. Age = PND 7
Independent Samples Tesf
L evene’s  T e st for
Equality of V ariances t-test for Equality of M eans
95%  C onfidence
Interval of the
M ean Std. Error D ifference
F Sig. t df Siq. (2-tailed) D ifference D ifference Lower U pper
G FA PvCT Equal v a rian ces  
a s s u m e d 5.159 .086
-2 870 4 .045 -5 .04000 1.75591 -9 .91519 -.16481
Equal v a rian ces  
not a s s u m e d -2.870 2.445
.082 -5 04000 1.75591 -11.41909 1 33909
S 1 0 0 v C T Equal v a rian ces  
a s s u m e d .078
.794 .499 4 .644 .20000 .40040 -.91170 1.31170
Equal v a rian ces  
not a s s u m e d .499 3.890 .644
.20000 .40040 - 92415 1 .32415
VIMENTINvCT Equal v a rian ces  
a s su m e d 3 8 2 3 .122 .556 4 .608
.30667 .55192 -1 .22570 1.83903
Equal v a rian ces  
not a s su m e d .556 2 .038 .633 .30667 .55192 -2 .02595 2 .63928
a. Age = PND 7
Age = PND 14
6 6
G roup Statistics’
Genotype N Mean S td  Deviat ion
S ta .  E ' ror 
M e a n
GFAPvCT Wild type 3 6 .9 3 0 0 .6 8 1 6 9 .3 9 3 5 7
Retinal degeneration 3 7 .3 8 6 7 .8 2 0 7 5 .4 7 3 8 6
SIOOvCT Wild type 3 5 .7 5 3 3 .27791 .1 6 0 4 5
Retinal degeneration 3 6 .1 8 6 7 .4 3 1 0 8 .2 4 8 8 9
VIMENTINvCT Wild type 3 6 .1 7 6 7 1 .0 8 3 0 7 .62531
Retinal degeneration 3 6 .2 4 3 3 1 .0 9 5 6 4 .6 3 2 5 7
a- Age = PND 14
Independent Samples Tesf
L ev en e  s  T e st ior
E quality of V ariances t-test for Equality of M ean s
95°= C on lid en ce
In terva of the
M ean S td  E rror D ifference
F Sig t df Sig. 12 -taded) D ifference D ifference cow er U pper
G FA PvC T E qual v a r ia n c e s  
a s s u m e d 232 655 -.741 4 500 -.45667
"
.61599 -2 16653 1 25360
Equal v a r ia n c e s  
not a s s u m e d -.741 3 .870 .501 - .45667 6 1 5 9 9 -2 .18989 1 .27656
SIOO vCT E qual v a r ia n c e s  
a s s u m e d .588 486 -1 .463 4 .217 - 4 3 3 3 3 2 9 6 1 2 -1 .25550 .38884
Equal v a r ia n c e s  
not a s s u m e d -1 4 63 3 .418 .229 -.43333 2 9 6 1 2 -1 .31382 .44716
VIM ENTINvCT E qual v a r ia n c e s  
a s s u m e d .028 .876 - 075 4 .944 -.06667 8 8 9 4 7 -2 .53623 2 .4 0 2 9 0
E qual v a r ia n c e s  
not a s s u m e d - 075 3 .999 .944 -.06667 .88947 -2 53636 2 403 0 3
a. A ge = PND  14
Age = PND 21
Group Statistics1
Genotype N Mean Std. Deviation
Std. Error 
Mean
GFAPvCT Wild type 3 5 .6 9 0 0 1 .1 0 3 2 2 .6 3 6 9 5
Retinal degeneration 3 6 .6 1 6 7 1 .5 0 6 7 3 .86991
SIOOvCT Wild type 3 5 .3 7 6 7 .3 6 1 1 6 .20851
Retinal degeneration 3 6 .0 7 6 7 .7 5 0 4 9 .4 3 3 2 9
VIMENTINvCT Wild type 3 5 .3 1 3 3 .1 5 0 4 4 .0 8 6 8 6
Retinal degeneration 3 6 .6 3 6 7 .5 6 0 3 9 .3 2 3 5 4
a- Age = PND 21
6 7
In d e p e n d e n t  S a m p le s  T e s t
L e v e n e 's  T est for
Equality of V ariances t-tes t fo Equality of M eans
95 '-. C o n ‘ qpr,.:e
ln te rva I c ‘ the
M ean Std. E r r o r D ifference
F Sig. t df Siq. (2-tailed! D ifference D ifference Lower U qper
G FA PvC T E qua l v a rian ces  
a s s u m e d .165 .705 -.859 4 .439 -.92667 1 .07817 -3 .92014 2 .06681
Equal v a r ia n c e s  
not a s s u m e d -.859 3 .666 .443 -.92667 1 .07817 -4 03094 2 .1 7 7 6 0
SIOO vCT E qual v a r ia n c e s  
a s s u m e d 3 .0 9 0 .154 -1 .456 4 .219 -.70000 .4 8 0 8 6 -2 035 0 7 .63507
E qua l v a r ia n c e s  
not a s s u m e d -1 .456 2 .879 .245 -.70000 480 8 6 -2 .26728 .86728
VIMENTINvCT E qua l v a rian ces  
a s s u m e d 7.711 .050 -3 .950 4 .017 -1 .32333 .33500 -2 .25343 -.39324
Equal v a r ia n c e s  
not a s s u m e d -3 .950 2 .287 .047 -1 .32333 .33500 -2.60461 -.04206
a- A ge = PN D  21
Age = PND 28
Group Statistics'
Genotype N Mean Std. Deviation
Std. Error 
Mean
GFAPvCT Wild type 3 7.4900 .57000 .32909
Retinal degeneration 3 5.8800 2.20361 1.27226
SIOOvCT Wild type 3 5.9800 .34176 .19732
Retinal degeneration 3 5.5667 .33126 .19125
VIMENTINvCT Wild type 3 5.1567 .87363 .50439
Retinal degeneration 3 5.1500 1.18655 .68505
a- Age = PND 28
Independent Sam ples Test
L e v e n e 's  T e s t  for 
E qua lity  of V a r ia n c e s t- te s t for E quality  of M e a n s
F Sig. t df S ig  (2 -ta iled )
M ean
D ifference
S td  Error 
D ifference
95 %  C o n fid e n c e  
In terval of th e  
D iffe rence
L ow er U pper
G F A P vC T  E qua l v a r ia n c e s  
a s s u m e d  
E q u a l v a r ia n c e s  
not a s s u m e d
7 .4 1 7 .0 5 3 1 2 2 5  
1 .225
4
2 .2 6 6
.2 8 8
.333
1 .6 1 0 0 0
1 .6 1 0 0 0
1 .3 1 4 1 3
1 .3 1 4 1 3
-2 .03861  
-3 4 5 2 6 8
5 .25861
6 .6 7 2 6 8
S IO O vC T  E q u a l v a r ia n c e s  
a s s u m e d  
E q u a l v a r ia n c e s  
not a s s u m e d
.004 .953 1 .504  
1 50 4
4
3 9 9 6
.207
20 7
4 1 3 3 3
.4 1 3 3 3
.27479
.27479
-.34961
-.34991
1 .1 7 6 2 8
1 .1 7 6 5 7
V IM ENTINvCT E q u a l v a r ia n c e s  
a s s u m e d  
E qua l v a r ia n c e s  
n o t a s s u m e d
.140 .727 .008
,008
4
3 6 7 6
.994
.994
.0 0 6 6 7
.0 0 6 6 7
.85071
85071
-2 3 5 5 2 9  
-2 .4 3 9 7 3
.
2 .3 6 8 6 2  
2 4 5 3 0 6
a A ge = P N D  28
Age = PND 35
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G roup S tatistics’
Genotype N Mean Std. Deviation
Std. Error 
Mean
GFAPvCT Wild type 3 7.2500 .95567 .55175
Retinal degeneration 3 7.1367 2.98825 1.72527
SIOOvCT Wild type 3 5.8867 . 18930 .10929
Retinal degeneration 3 6.9100 1.75855 1.01530
VIMENTINvCT Wild type 3 5.5400 .62362 .36005
Retinal degeneration 3 7.4367 2.61098 1.50745
a- Age = PND 35
Independent Samples Test
L e v e n e 's  T e st for
Eoualitv of V arian ces t-test for Equalitv of M eans
95°o C onfidence
Interval of the
S td . Error D ifference
F Sig t df Siq. (2 -ta iled> D ifference D ifference Lower U pper
G FA PvC T E qual v a ria n c e s  
a s s u m e d 2 .712 .175 .063 4 .953 11333 1.81135 -4 91577 5 .14244
E qual v a r ia n c e s  
not a s s u m e d .063 2.405 .955 .11333 1.81135 -6 .54858
6 7 7 5 2 4
SIOO vCT E qual v a r ia n c e s  
a s s u m e d 4 .3 6 2 .105 -1 .002 4 .373 -1 .02333 1.02116 -3 .85854 1.81187
E qual v a r ia n c e s  
not a s s u m e d -1 .002 2 .046 .420 -1 02333 1.02116 -5 .32306 3 .27640
VIMENTINvCT E qual v a r ia n c e s  
a s s u m e d 4 .1 3 5 .112 -1 224 4 .288 -1 .89667 1.54985 -6 .19975
2 40642
E qua l v a r ia n c e s  
not a s s u m e d -1 .224 2 .227 .335 -1 89667 1.54985 -7 .95330
4 .15997
a. A ge = PND 35
Age = PND 42
Group Statistics’
Genotype N Mean Std. Deviation
Std. Error 
Mean
GFAPvCT Wild type 3 7.2033 .67412 .38920
Retinal degeneration 3 7.5933 .80451 .46448
SIOOvCT Wild type 3 6.1433 .57047 .32936
Retinal degeneration 3 5.2433 .95044 .54874
VIMENTINvCT Wild type 3 7.2800 .82438 .47596
Retinal degeneration 3 6.0733 .63885 36884
a. Age = PND 42
6 9
In d e p e n d e n t S a m p le s  T e s f
Levene's T est for
Equality of V ariances l-iest for Eauaut/ of M eans
9 5 ':  Confidence
Interva cf toe
Mean Std Error Difference
F Siq. t df Siq. (2-tailed) Difference Difference Lower U ppe'
GFAPvCT Equal variances 
as su m e d .092 .777 -.644 4 .555 -.39000 .60599 -2.07249 1 29249
Equal variances 
not a s su m ed - 644 3.881 .556 -.39000 60599 -2.09301 '1 31301
SIOOvCT Equal variances 
a s su m e d .517 .512 1.406 4 232 .90000 .63999 -.37690 2.67690
Equal variances 
not a s su m ed 1.406 3.275 .247 .90000 .63999 -1.04318 2.84318
VIMENTINvCT Equal v ariances  
a s su m ed .414 .555 2,004 4 .116 1.20667 .60214 -.46515 2,87849
Equal variances 
not a s su m ed 2.004 3.765 120 1.20667 .60214 -.50703 2.92037
a  Age = PND 42
Age = PND 49
Group Statistics1
Genotype N Mean Std. Deviation
Std. Error 
Mean
GFAPvCT Wild type 3 7.0267 .75725 .43720
Retinal degeneration 3 9.9900 1.48698 .85851
SIOOvCT Wild type 3 5.2633 .30989 .17892
Retinal degeneration 3 6.6733 .60476 .34916
VIMENTINvCT Wild type 3 6.6300 .97780 .56454
Retinal degeneration 3 6.4433 .74648 .43098
a- Age = PND 49
Independent Samples Tes!
L e v e n e 's  T e st for 
Equality of V arian c es t-tes t for Equality of M eans
F Sig. t df Siq. (2-tailed)
M ean
D ifference
S td. Error 
D ifference
95%  C onfidence 
Interval of the 
D ifference
Low er U pper
G FA P vC T  E qua l v a r ia n c e s  
a s s u m e d  
E qua l v a r ia n c e s  
no t a s s u m e d
1.883 .242 -3.076
-3 .076
4
2 .972
.037
.055
-2 .96333
-2 .96333
.96342
.96342
-5 .63822
-6 .04577
-.28845
.11911
SIO O vCT E qua l v a r ia n c e s  
a s s u m e d  
E q u a l v a r ia n c e s  
not a s s u m e d
2 .3 1 9 .202 -3 .594
-3 .594
4
2 .9 8 3
.023
.037
-1 .41000
-1 .41000
.39233
.39233
-2 .49928
-2.66271
-.32072
-.15729
VIMENTINvCT E qua l v a r ia n c e s  
a s s u m e d  
E q u a l v a r ia n c e s  
not a s s u m e d
.324 .599 .263
.263
4
3 .740
.806
.807
.18667
.18667
71024
.71024
-1 .78528
-1 .84050
2 15862 
2 213 8 3
a . A ge = PND  49
Age = PND 100
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G roup  S tatis tics3
Genotype N Mean Std. Deviation
Std. Error 
Mean
GFAPvCT Wild type 3 7.1367 1.82626 1.05439
Retinal degeneration 3 7.1233 2.19983 1.27007
SIOOvCT Wild type 3 5.2833 1.20272 .69439
Retinal degeneration 3 5.4133 2.57754 1.48815
VIMENTINvCT Wild type 3 6.0433 1.04673 .60433
Retinal degeneration 3 7.1900 .68790 .39716
a- Age = PND 100
Independent Samples Test
L e v e n e 's  T e st tor
Equality of V ariances t-test for Equality of M eans
OS'G C onfidence
Interval ot the
M ean S td  Error D ifference
F S'Q. t df Siq. (2-tailed) D ifference D 'flerence Lower U pper
G FA P vC T  Equal v a r ian ces  
a s s u m e d .293 617 .008 4 .994 01333 1 .65070 -4 .56975 4 59642
Equal v a rian ces  
not a s s u m e d .008 3.869 994 .01333 1 .65070 -4.63-! 59 4 65826
SIO O vCT Equal v a r ia n c e s  
a s s u m e d 1.345 .311 -.079 4 .941 -.13000 1 .64218 -4 .68942 4 .42942
E qual v a rian ces  
not a s s u m e d -.079 2.831 .942 -.13000 1 .64218 -5 .53658 5 .27658
VIMENTINvCT E qual v a r ia n c e s  
a s s u m e d 1.248 .326 -1.586 4 188 -1 .14667 .72315 -3 15445 .86112
E qual v a r ia n c e s  
not a s s u m e d -1 .586 3.456 .199 -1 .14667 .72315 -3 28545 99212
a. A ge = PND 100
Age = PND 140
Group Statistics'
Genotype N Mean Std. Deviation
Std. Error 
Mean
GFAPvCT Wild type 5 7.7400 1.36129 .60879
Retinal degeneration 5 6.6780 1.72911 .77328
SIOOvCT Wild type 5 5.9960 .68937 .30830
Retinal degeneration 5 5.1820 1.35210 .60468
VIMENTINvCT Wild type 5 5.8460 1.13813 .50899
Retinal degeneration 5 5.9700 1.32575 .59289
a. Age = PND 140
7 1
In d e p e n d e n t S a m p le s  T e s t1
L evene’s T est for
Equality of V ariances t-test *o E a u a 1 ly r ' ' "cans
M ean SM E nor
‘ " ’b r . ft 
C ' ,fe
- C  . - 1-
: e
F Sig t d ' Siq. 12-tailedi Difference D ifference Lc.ve- J r .o e '
G FA P vCT E q ja l va riances  
a s su m e d .449 .522 1.079 8 .312 1.00200 .98417 -1 .20749 2 3 3 '4 9
Equal v a rian ces  
not a s su m ed 1 079 7.582 .314 1.06200 98417 -1 22944 3 35344
SIOOvCT Equal v ariances  
a s su m e d 1.304 .287 1.199 8 .265 .81400 .67873 - 75116 2 37916
Equal v ariances  
not a s su m ed 1.199 5 948 .276 .81400 67873 -.85033 2 47833
VIMENTtNvCT Equal va rian ces  
a s su m ed .001 .977 - 159 6 .878 -.12400 .78140 -1.92591 1 67791
Equal v a rian ces  
not a s su m e d -.159 7.821 878 - 12400 78140 -1 .93313 1.68513
a  A ge = PND 140
Age = PND 250
Group Statistics’
Genotype N Mean Std. Deviation
Std. Error 
Mean
GFAPvCT Wild type 3 7.5333 2.11382 1.22041
Retinal degeneration 3 9.8233 3.43957 1.98584
SIOOvCT Wild type 3 6.0700 .39395 .22745
Retinal degeneration 3 5.9700 2.66494 1.53860
VIMENTINvCT Wild type 3 6.0433 1.41047 .81434
Retinal degeneration 3 6.5600 1.22233 .70571
a- Age = PND 250
Independent Samples Test
L e v e n e 's  T e s t for
Equality of V arian ces t-tes t for Equality of M ean s
95 %  C onfidence
Interval of the
M ean Std, Error D ifference
p Sig t df Sig. (2-tailed) D ifference D ifference Lower U pper
G FA P vC T  E qual v a r ia n c e s  
a s s u m e d 1,412 .300 - 982
4 .381 -2 .29000 2 3 3 0 8 7 -8 .76153 4 .1 8 1 5 3
E qual v a r ia n c e s  
not a s s u m e d
-.982 3 .322 .392 -2 .29000 2 .3 3 0 8 7 -9 .31710 4 .7 3 7 1 0
SIOO vCT E qua l v a r ia n c e s  
a s s u m e d 4.521 .101
.064 4 .952 .10000 1 .55532 -4 218 2 7 4 .41827
E qua l v a r ia n c e s  
not a s s u m e d
064 2 .087 .954 . '0 0 0 0 1 55532 -6 33063 6 .5 3 0 6 3
vTMENTiNvCT E qua l v a r ia n c e s  
a s s u m e d .008
.931 -.479 4 .657 -.51667 1 .07758 -3 50851 2 475 1 7
E qua l v a r ia n c e s  
not a s s u m e d
- 479 3.921 .657 -.51667 1 .07758 -3 53252 2 .49918
a A ge = PND 250
13) G raphing \C t for each gene syntax using SPSS
* Here we turn off the splitting of the file.
SPLIT FILE
OFF.
* W e produced a line graph with AgeTTime/Day on the x-axis and cycles on the y-axis and with a 
seperate line for each of the 2 genomes for gene GFAPvCT.
GRAPH
/LINE(M ULTIPLE)MEAN(GFAPvCT) BY Age BY Genotype 
/INTERVAL SE( 1).
GRAPH
/LINE(M ULTIPLE)M EAN(S100vCT) BY Age BY Genotype 
/INTERVAL SE( 1).
GRAPH
/LINE(MULTIPLE)M EAN(VIM ENTINvCT) BY Age BY Genotype 
/INTERVAL SE( 1).
14) Syntax for non parametric test kruskal-wallis test
SORT CASES BY Age .
SPLIT FILE 
SEPARATE BY Age .
NPAR TESTS
/K-W =GFAPvCT SIOOvCT VIMENTINvCT BY Genotype(1 2)
/M ISSING ANALYSIS.
15) Non-param etric kruskal-wallis test output each gene/age using SPSS
NPar Tests Kruskal-Wallis Test
[DataSetl] H:\research 2007\results stats for thesis as of 5-i 1-2008\Rax 
and delta Ct values for glial genes 5-12-2 003.sav 
Age = PND 7
Ranks3
G e n o ty p e N M ean Rank
G F A PvC T  Wild type 3 2.00
Retinal d eg en e ra t io n 3 5 00
Total 6
SIOOvCT Wild type 3 4.00
Retinal deg en e ra t io n 3 3.00
Total 6
VIMENTINvCT Wild type 3 4.00
Retinal deg en e ra t io n 3 3.00
Total 6
a Age = PND 7
7 3
T e s t S ta tis tics? 15 c
GFAPvCT SIOOvCT VIMENTINvCT
Chi-Square 3.857 .429 .429
df 1 1 1
Asymp. Sig. .050 .513 .513
a- Kruskal Wallis Test 
b Grouping Variable: Genotype 
c- Age = PND 7
Age = PND 14
Ranks3
G eno type N Mean Rank
G F A PvC T  Wild type 3 3.00
Retinal d eg en e ra t io n 3 4 .00
Total 6
SIOOvCT Wild type 3 2.33
Retina! deg en e ra t io n 3 4.67
Total 6
VIMENTINvCT Wild type 3 3.67
Retinal d eg en e ra t io n 3 3 33
Total 6
a- Age = PND 14
Test Statistics3’15’0
GFAPvCT SIOOvCT VIMENTINvCT
Chi-Square .429 2.333 .048
df 1 1 1
Asymp. Sig. .513 .127 .827
a - Kruskal Wallis Test 
b- Grouping Variable: Genotype 
c. Age = PND 14
Age = PND 21
Ranks3
G e n o ty p e N M ean R an k
G F A PvC T  Wild type 3 2.67
Retinal d e g e n e r a t io n 3 4 .33
Total 6
SIOOvCT Wild type 3 2.67
Retinal d e g e n e ra t io n 3 4 .33
Total 6
VIMENTINvCT Wild type 3 2 .00
Retinal d e g e n e ra t io n 3 5 .00
Total 6
a. Age = PND 21
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T e s t S ta tis tic s 3 b c
GFAPvCT SIOOvCT VIMENTINvCT
Chi-Square 1.190 1.190 3.857
df 1 1 1
Asymp. Sig. .275 .275 .050
a- Kruskal Wallis Test 
b- Grouping Variable: Genotype 
c - Age = PND 21
Age = PND 28
Ranks3
Genotype N Mean Rank
GFAPvC T Wild type 3 4.00
Retinal degeneration 3 3.00
Total 6
SIOOvCT Wild type 3 4.67
Retinal degenerat ion 3 2.33
Total 6
VIMENTINvCT Wild type 3 3.33
Retinal degenerat ion 3 3.67
Total 6
a  Age = PND 28
Test Statistics?*30
GFAPvCT SIOOvCT VIMENTINvCT
Chi-Square .429 2.333 .048
df 1 1 1
Asymp. Sig. .513 .127 .827
a- Kruskal Wallis Test 
b- Grouping Variable: Genotype 
c. Age = PND 28
Age = PND 35
Ranks3
G e n o ty p e N M ean  Rank
G F A P v C T  Wild type 3 3 .33
Retinal d e g e n e ra t io n 3 3.67
Total 6
SIOOvCT Wild type 3 3 .00
Retinal d e g e n e ra t io n 3 4 .00
Total 6
VIMENTINvCT Wild type 3 3 .00
Retinal d e g e n e ra t io n 3 4 .0 0
Total 6
a. Age = PND 35
7 5
T e s t S ta tis tic s3 b c
GFAPvCT SIOOvCT VIMENTINvCT
Chi-Square .048 .429 ,429
df 1 1 1
Asymp. Sig. .827 .513 .513
a- Kruskal Wallis Test 
b Grouping Variable: Genotype 
c - Age = PND 35
Age = PND 42
Ranks3
G enotype N Mean Rank
G F A P v C T  Wild type 3 2.67
Retinal d e gene ra t ion 3 4.33
Total 6
SIOOvCT Wild type 3 4.33
Retinal deg en e ra t io n 3 2.67
Total 6
VIMENTINvCT Wild type 3 4.67
Retinal d eg en e ra t io n 3 2.33
Total 6
a  Age = PND 42
Test Statistics?’6,0
GFAPvCT SIOOvCT VIMENTINvCT
Chi-Square 1.190 1.190 2.333
df 1 1 1
Asymp. Sig. .275 .275 .127
a Kruskal Wallis Test 
b- Grouping Variable: Genotype
c. Age = PND 42
Age = PND 49
Ranks3
G en o ty p e N Mean R ank
G F A PvC T  Wild type 3 2 .00
Retinal d eg en e ra t io n 3 5.0  0
Total 6
SIOOvCT Wild type 3 2.00
Retinal d e g en e ra t io n 3 5.00
Total 6
VIMENTINvCT Wild type 3 3.67
Retinal d e g en e ra t io n 3 3.33
Total 6
a Age = PND 49
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T e s t S ta tis tic s3 b c
GFAPvCT SIOOvCT VIMENTINvCT
Chi-Square 3.857 3.857 .048
df 1 1 1
Asymp. Sig. .050 .050 .827
a- Kruskal Wallis Test 
b- Grouping Variable: Genotype 
c - Age = PND 49
Age = PND 100
Ranks3
Genotype N Mean Rank
GFAPvCT Wild type 3 3.33
Retinal degeneration 3 3 67
Total 6
SIOOvCT Wild type 3 3.33
Retinal degeneration 3 3.67
Total 6
VIMENTINvCT Wild type 3 2.33
Retinal degeneration 3 4.67
Total 6
a- Age = PND 100
Test Statistics3,13,0
GFAPvCT SIOOvCT VIMENTINvCT
Chi-Square .048 .048 2.333
df 1 1 1
Asymp. Sig. .827 .827 .127
a - Kruskal Wallis Test 
b Grouping Variable: Genotype 
c. Age = PND 100
Age = PND 140
Ranks3
G enotype N Mean Rank
GFAPvCT Wild type 5 6 0 0
Retinal degenera t ion 5 5.00
Total 10
SIOOvCT Wild type 5 6.60
Retinal degenerat ion 5 4.40
Total 10
VIMENTINvCT Wild type 5 5.40
Retinal degenera t ion 5 5.60
Total 10
3- Age = PND 140
7 7
T e s t S ta tis tic s3 b,c
GFAPvCT SIOOvCT VIMENTINvCT
Chi-Square .273 1.320 .011
df 1 1 1
Asymp. Sig. .602 .251 .917
a Kruskal Wallis Test 
b- Grouping Variable: Genotype 
c - Age = PND 140
Age = PND 250
Ranks3
G enotype N Mean Rank
G F A P v C T  Wild type 3 2.67
Retinal d e gene ra t ion 3 4.33
Total 6
SIOOvCT Wild type 3 3.33
Retinal deg en e ra t io n 3 3.67
Total 6
VIMENTINvCT Wild type 3 3 .00
Retinal d eg en e ra t io n 3 4 .0 0
Total 6
a  Age = PND 250
Test Statistics3,5,0
GFAPvCT SIOOvCT VIMENTINvCT
Chi-Square 1.190 .048 .429
df 1 1 1
Asymp. Sig. .275 .827 .513
Kruskal Wallis Test
b. Grouping Variable: Genotype
c. Age = PND 250
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